{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import urllib.request, urllib.parse, urllib.error\n",
    "from bs4 import BeautifulSoup\n",
    "import requests\n",
    "target_url = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762458/'\n",
    "'''\n",
    "###방법 1\n",
    "###html 문서를 가져옵니다.\n",
    "html = urllib.request.urlopen(target_url).read()\n",
    "\n",
    "###html 문서를 파싱합니다.\n",
    "soup = BeautifulSoup(html, 'html.parser')\n",
    "'''\n",
    "###방법2\n",
    "###html 문서를 가져옵니다\n",
    "res = requests.get(target_url)\n",
    "res = res.text \n",
    "\n",
    "###html 문서를 파싱합니다.\n",
    "soup = BeautifulSoup(res, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "###html 문서를 보기 편하게 합니다.\n",
    "#print(soup.prettify())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<title>Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</title>\n"
     ]
    }
   ],
   "source": [
    "### <title>The Dormouse's story</title>\n",
    "print(soup.title)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "title\n"
     ]
    }
   ],
   "source": [
    "### u'title'\n",
    "print(soup.title.name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study\n"
     ]
    }
   ],
   "source": [
    "### u'The Dormouse's story'\n",
    "print(soup.title.string)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "head\n"
     ]
    }
   ],
   "source": [
    "### u'head'\n",
    "print(soup.title.parent.name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<p class=\"etc_btn\">\n",
      "<a class=\"sch_dt\" href=\"/ndsl/search/detail/articleDetailsearch.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"상세검색\">상세검색</a>\n",
      "<a class=\"multi_kb\" href=\"javascript:void(0);\" onclick=\"fncLangModalOpen();\" title=\"다국어 입력창 열기\">다국어입력</a>\n",
      "</p>\n"
     ]
    }
   ],
   "source": [
    "### <p class=\"title\"><b>The Dormouse's story</b></p>\n",
    "print(soup.p)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['etc_btn']\n",
      "<span>본문 바로가기</span>\n"
     ]
    }
   ],
   "source": [
    "### u'title'\n",
    "print(soup.p['class'])\n",
    "print(soup.span)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<a href=\"#container\"><span>본문 바로가기</span></a>\n"
     ]
    }
   ],
   "source": [
    "### <a class=\"sister\" href=\"http://example.com/elsie\" id=\"link1\">Elsie</a>\n",
    "print(soup.a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[<a href=\"#container\"><span>본문 바로가기</span></a>, <a href=\"/ndsl/main/main.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\">NDSL</a>, <a class=\"sel_btn\" href=\"javascript:void(0);\" id=\"selTxt\" onclick=\"fncPopupOpen(this,'menuModal');\">전체</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>chr</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>d</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>ilfold</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>nd</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>nd flash</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>nda</a>, <a href=\"javascript:void(0);\"><span class=\"txt_em\">na</span>no</a>, <a href=\"javascript:void(0);\">coro<span class=\"txt_em\">na</span></a>, <a href=\"javascript:void(0);\">d<span class=\"txt_em\">na</span></a>, <a href=\"javascript:void(0);\">alumi<span class=\"txt_em\">na</span></a>, <a href=\"javascript:void(0);\">antenna<span class=\"txt_em\">na</span></a>, <a href=\"javascript:void(0);\">microrna<span class=\"txt_em\">na</span></a>, <a class=\"sch_dt\" href=\"/ndsl/search/detail/articleDetailsearch.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"상세검색\">상세검색</a>, <a class=\"multi_kb\" href=\"javascript:void(0);\" onclick=\"fncLangModalOpen();\" title=\"다국어 입력창 열기\">다국어입력</a>, <a class=\"btn_logout\" href=\"javascript:void(0);\" title=\"로그인\"><span class=\"ico_ndsl ico_user\"></span>로그인</a>, <a href=\"javascript:void(0);\" id=\"menuIcon\" title=\"메뉴보기\"><span class=\"ico_ndsl ico_menu\"></span>메뉴보기</a>, <a href=\"javascript:void(0);\" onclick=\"javascript:fncPinLogInsert('P01', this, 'U', 'http://www.ndsl.kr/ndsl/about/ed/infosearchNdPrcuse.do'); return false;\" target=\"_blank\">\n",
      "<img alt=\"NDSL 정보검색 가이드\" src=\"http://www.ndsl.kr/ndsl/commons/util/imgFileView.do?gubun=banner&amp;fileNm=20180423_435940404509082.png\"/>\n",
      "<span class=\"box_border\"></span>\n",
      "</a>, <a class=\"cnType\" data-type=\"recomend\" href=\"javascript:void(0);\">추천</a>, <a class=\"cnType\" data-type=\"all\" href=\"javascript:void(0);\">전체</a>, <a class=\"main_tab_btn\" data-col=\"pp\" data-type=\"all\" href=\"javascript:void(0);\">논문</a>, <a class=\"main_tab_btn\" data-col=\"pt\" data-type=\"all\" href=\"javascript:void(0);\">특허</a>, <a class=\"main_tab_btn\" data-col=\"rp\" data-type=\"all\" href=\"javascript:void(0);\">보고서</a>, <a class=\"main_tab_btn\" data-col=\"tr\" data-type=\"all\" href=\"javascript:void(0);\">동향</a>, <a class=\"main_tab_btn\" data-col=\"pp\" data-type=\"recomend\" href=\"javascript:void(0);\">추천논문</a>, <a class=\"main_tab_btn\" data-col=\"pt\" data-type=\"recomend\" href=\"javascript:void(0);\">추천특허</a>, <a class=\"main_tab_btn\" data-col=\"rp\" data-type=\"recomend\" href=\"javascript:void(0);\">추천보고서</a>, <a class=\"main_tab_btn\" data-col=\"tr\" data-type=\"recomend\" href=\"javascript:void(0);\">추천동향</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015014742' , '학위논문 all scholar' , this);\" title=\"화장품 개발을 위한 남천의 항염 및 항알레르기 효능 평가\">화장품 개발을 위한 남천의 항염 및 항알레르기 효능 평가</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015025596' , '학위논문 all scholar' , this);\" title=\"영아반 보육교사의 &lt;!HS&gt;미세먼지&lt;!HE&gt; 인식과 실내대체활동 실태조사\">영아반 보육교사의 <!--HS-->미세먼지<!--HE--> 인식과 실내대체활동 실태조사</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015013963' , '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt;에 관한 유아교사의 인식과 대응 및 교육 실태\"><!--HS-->미세먼지<!--HE-->에 관한 유아교사의 인식과 대응 및 교육 실태</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015015880' , '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt;의 결정요인에 관한 연구\"><!--HS-->미세먼지<!--HE-->의 결정요인에 관한 연구</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015015935' , '학위논문 all scholar' , this);\" title=\"빌딩에너지관리시스템(BEMS)을 위한 분산데이터 처리시스템 구현\">빌딩에너지관리시스템(BEMS)을 위한 분산데이터 처리시스템 구현</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015025483' , '학위논문 all scholar' , this);\" title=\"WRF-Chem과 WRF/CMAQ 모형의 &lt;!HS&gt;미세먼지&lt;!HE&gt; 모의 성능 비교\">WRF-Chem과 WRF/CMAQ 모형의 <!--HS-->미세먼지<!--HE--> 모의 성능 비교</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015025460' , '학위논문 all scholar' , this);\" title=\"GWR 모델을 활용한 &lt;!HS&gt;미세먼지&lt;!HE&gt;(PM10) 오염농도와 토지피복간의 상관성 평가 : 경기도 남부 지역을 중심으로\">GWR 모델을 활용한 <!--HS-->미세먼지<!--HE-->(PM10) 오염농도와 토지피복간의 상관성 평가 : 경기도 남부 지역을 중심으로</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015025492' , '학위논문 all scholar' , this);\" title=\"겨울철 한반도 PM10 농도의 경년 변동에 대한 북극 해빙의 영향\">겨울철 한반도 PM10 농도의 경년 변동에 대한 북극 해빙의 영향</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0015070065' , '학위논문 all scholar' , this);\" title=\"고전압 공진형 컨버터의 설계와 플라즈마 전기집진기의 응용\">고전압 공진형 컨버터의 설계와 플라즈마 전기집진기의 응용</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('NART96373975' , '국내논문 all scholar' , this);\" title=\"An Automated Tracking System of Fine Dust Generating Spot for Building Dismantlement Sites\">An Automated Tracking System of Fine Dust Generating Spot for Building Dismantlement Sites</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014516178', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 자료동화 및 통합예보모형 개발연구\"><!--HS-->미세먼지<!--HE--> 자료동화 및 통합예보모형 개발연구</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('NPAP12898265', '국내논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 저감 및 관리에 관한 입법 및 정책적 검토\"><!--HS-->미세먼지<!--HE--> 저감 및 관리에 관한 입법 및 정책적 검토</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('JAKO201867551544620', '국내논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 해법의 올바른 방향 - &lt;!HS&gt;미세먼지&lt;!HE&gt; 대응, 새로운 방향 설정이 필요하다\"><!--HS-->미세먼지<!--HE--> 해법의 올바른 방향 - <!--HS-->미세먼지<!--HE--> 대응, 새로운 방향 설정이 필요하다</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014577260', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 위험지각과 마스크 착용 증진방안에 관한 연구\"><!--HS-->미세먼지<!--HE--> 위험지각과 마스크 착용 증진방안에 관한 연구</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0013283745', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; PM10 증가에 따른 사망률 변화에 대한 체계적 문헌고찰\"><!--HS-->미세먼지<!--HE--> PM10 증가에 따른 사망률 변화에 대한 체계적 문헌고찰</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014857846', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 위험에 대한 인식과 소셜미디어 의존이 &lt;!HS&gt;미세먼지&lt;!HE&gt;에 대한 대응행동에 미치는 영향\"><!--HS-->미세먼지<!--HE--> 위험에 대한 인식과 소셜미디어 의존이 <!--HS-->미세먼지<!--HE-->에 대한 대응행동에 미치는 영향</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014730313', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 관련 질병 데이터 모형 연구\"><!--HS-->미세먼지<!--HE--> 관련 질병 데이터 모형 연구</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014897285', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 농도에 따른 환경에서 운동이 심폐기능과 유산소운동능력에 미치는 영향\"><!--HS-->미세먼지<!--HE--> 농도에 따른 환경에서 운동이 심폐기능과 유산소운동능력에 미치는 영향</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0013840163', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 중량측정법의 신뢰성 확보를 위한 정도 관리 및 불확도 최소화 방안 연구\"><!--HS-->미세먼지<!--HE--> 중량측정법의 신뢰성 확보를 위한 정도 관리 및 불확도 최소화 방안 연구</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoToDetail('DIKO0014516178', '학위논문 all scholar' , this);\" title=\"&lt;!HS&gt;미세먼지&lt;!HE&gt; 자료동화 및 통합예보모형 개발연구\"><!--HS-->미세먼지<!--HE--> 자료동화 및 통합예보모형 개발연구</a>, <a class=\"set\" href=\"javascript:void(0);\" onclick=\"javascript:fncPopupOpen(this, 'registLayer'); return false;\">등록</a>, <a class=\"trend_tab_btn\" data-type=\"GTB\" href=\"javascript:void(0);\">과학기술동향</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005439' , this);\" style=\"width: 100%;\">파킨슨병에서 혈액에 있는 면역 세포의 거동</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005440' , this);\" style=\"width: 100%;\">심장병, 비만, 제2형 당뇨병 퇴치에 도움이 될 수 있는 효소 발견</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005437' , this);\" style=\"width: 100%;\">자녀 비만과 연관된 임신 중 높은 납 농도</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005438' , this);\" style=\"width: 100%;\">심부전과 비만의 역설</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005434' , this);\" style=\"width: 100%;\">약물 혼합 치료로 초파리 생명 연장</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005435' , this);\" style=\"width: 100%;\">몸무게 증가와 장내 세균을 연결하는 분자</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005436' , this);\" style=\"width: 100%;\">영국 정부의 데이터 전략에 대한 비판</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005429' , this);\" style=\"width: 100%;\">프랑스 연구팀, 머신러닝을 통한 자폐증 치료용 이모페이스(Emoface) 개발</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005430' , this);\" style=\"width: 100%;\">프랑스국립과학연구원, 암진단용 바이오마커 탐지 기술 상용화 착수</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005431' , this);\" style=\"width: 100%;\">바이오연료 생산을 위한 맞춤형 미생물을 개발한 미국</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005432' , this);\" style=\"width: 100%;\">신재생에너지에 미화 20억불 이상을 투자하는 Google</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005433' , this);\" style=\"width: 100%;\">전 원전에 대한 2번째 운영허가 갱신을 추진하는 미 Duke사</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005419' , this);\" style=\"width: 100%;\">돼지 열병의 확산에 영향을 끼치는 중요한 요소들</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005420' , this);\" style=\"width: 100%;\">인공지능과 기기학습이 접목된 인공 팔의 기술개발 동향</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005421' , this);\" style=\"width: 100%;\">인공지능이 기업 및 조직에 미치는 영향은 어느 수준인가?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005422' , this);\" style=\"width: 100%;\">자동화된 무기로 인해 우발적인 차세대 세계대전 발발 위험성 경고</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005423' , this);\" style=\"width: 100%;\">인공지능 사용에 따라 편향된 부작용의 발생을 우려하고 있는 영국 경찰</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005424' , this);\" style=\"width: 100%;\">기술 대기업들의 인공지능을 개발이 세계를 위험에 빠뜨리고 있다</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005425' , this);\" style=\"width: 100%;\">악성코드를 활용한 스마트TV 제조사들의 데이터 유출 실태</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005426' , this);\" style=\"width: 100%;\">운송, 선적, 유틸리티를 대상으로 삼은 신종 악성코드 출현</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005427' , this);\" style=\"width: 100%;\">옥스포드 연구진, 인공지능을 활용해 영장류 안면인식기술 개발에 성공</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('GTB2019005428' , this);\" style=\"width: 100%;\">애견 비만에 대한 새로운 연구</a>, <a class=\"trend_tab_btn\" data-type=\"SCTM\" href=\"javascript:void(0);\">사이언스타임즈</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198233' , this);\" style=\"width: 100%;\">석유 화학의 쌀 '에틸렌'의 재발견</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198244' , this);\" style=\"width: 100%;\">“초연결 시대는 새로운 기회다”</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198228' , this);\" style=\"width: 100%;\">세계가 주목할 비즈니스 트렌드는?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198258' , this);\" style=\"width: 100%;\">생체반응이 감정반응의 객관적 지표?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198275' , this);\" style=\"width: 100%;\">범죄수사용, 모발 분석 기법 개발</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198211' , this);\" style=\"width: 100%;\">노화방지 의약품, 2년 내 실현되나?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198195' , this);\" style=\"width: 100%;\">과학자 1만 명, 기후변화 비상선언</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198201' , this);\" style=\"width: 100%;\">조류도 유인원만큼 복잡한 사회 구성</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198185' , this);\" style=\"width: 100%;\">탄소를 전혀 배출하지 않는 농장 구현</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198162' , this);\" style=\"width: 100%;\">태양계 끝에서 무슨 일이?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198099' , this);\" style=\"width: 100%;\">소형 발사체 개발 열기 '후끈'</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198131' , this);\" style=\"width: 100%;\">이달 중 계절관리제 세부 방안 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198148' , this);\" style=\"width: 100%;\">온실가스 먹는 미생물의 움직임 규명</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198096' , this);\" style=\"width: 100%;\">최초의 시간여행 SF는 '마하바라타'</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198038' , this);\" style=\"width: 100%;\">생각만으로 군용 드론을 조종한다?</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198077' , this);\" style=\"width: 100%;\">환경문제 조기 대응 기술 개발 주력</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198105' , this);\" style=\"width: 100%;\">육식 수각공룡 먹이 기반 넓었다</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198083' , this);\" style=\"width: 100%;\">미래 과학‧수학 이끌 주인공 모였다</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198116' , this);\" style=\"width: 100%;\">흡혈박쥐, 환경 바뀌어도 '우정' 유지</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198059' , this);\" style=\"width: 100%;\">태양계 밖서 온 혜성…물 갖고 있어</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198045' , this);\" style=\"width: 100%;\">3D 프린팅 제조 혁신 방안 논의</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('SCTM00198046' , this);\" style=\"width: 100%;\">배아 발달의 '블랙박스' 열다</a>, <a class=\"trend_tab_btn\" data-type=\"ECMS\" href=\"javascript:void(0);\">과학향기</a>, <a class=\"link\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6043' , this);\">\n",
      "<div class=\"thum_box\">\n",
      "<img alt=\"코골이, 무서운 질환으로 이어질 수 있어\" onerror=\"this.src='/common/images/main/scon_img1.png'\" src=\"http://scent.ndsl.kr//uploadfile/ecms/media/2019/11/2d989e7fb80872bca7a74a2edc8ceae4.png\"/>\n",
      "<span class=\"box_border\"></span>\n",
      "</div>\n",
      "<div class=\"txt_box\">\n",
      "<p><strong>코골이, 무서운 질환으로 이어질 수 있어</strong>코골이는 피곤해서, 나이가 들어서 자연스레 생기는 신체 변화로, 단지 주변 사람을 괴롭게 하는 버릇으로 알고 있는 사람이 많다. 물론 대개는 그렇지만 코골이가 생명을 위협할 수도 있다.   코골이, 수면무호흡으로 이어진다   코를 고는 사람 중 다수가 수면무호흡 증상을 보인다. 원인이 코골이와 비슷하기 때문인데, 코골이가 기도가 좁아져서 나타나는 현상이라면 수면무호흡은 좁은 기도가 더 좁아지면서 숨길이 막혀 호흡이 일시적으로 멈추는 증상이다. 평균 10초 이상 숨을 쉬지 않는 무호흡이 시간당 5회 이상 또는 7시간 ...</p>\n",
      "</div>\n",
      "</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6040' , this);\" style=\"width: 100%;\" title=\"전자담배 주의보, 폐질환 환자가 늘어간다\">전자담배 주의보, 폐질환 환자가 늘어간다</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6037' , this);\" style=\"width: 100%;\" title=\"늦잠 자는 이유, 의지만의 문제가 아니야\">늦잠 자는 이유, 의지만의 문제가 아니야</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6034' , this);\" style=\"width: 100%;\" title=\"일본의 원전 오염수 해양 유출, 괜찮은 걸까?\">일본의 원전 오염수 해양 유출, 괜찮은 걸까?</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6030' , this);\" style=\"width: 100%;\" title=\"지문은 도대체 왜 생겼을까?\">지문은 도대체 왜 생겼을까?</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6027' , this);\" style=\"width: 100%;\" title=\"나노기술의 상용화를 글로벌 나노 축제, 나노 테크 재팬(1)\">나노기술의 상용화를 글로벌 나노 축제, 나노 테크 재팬(1)</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6024' , this);\" style=\"width: 100%;\" title=\"급속냉동식품은 어떻게 탄생했을까?\">급속냉동식품은 어떻게 탄생했을까?</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6021' , this);\" style=\"width: 100%;\" title=\"[데이터 과학-2] 인공지능에게 필요한 데이터는 특별하다!\">[데이터 과학-2] 인공지능에게 필요한 데이터는 특별하다!</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6018' , this);\" style=\"width: 100%;\" title=\"소중한 지구, 해양 쓰레기로 몸살을 앓고 있다\">소중한 지구, 해양 쓰레기로 몸살을 앓고 있다</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6015' , this);\" style=\"width: 100%;\" title=\"폐사율 100%, 아프리카돼지열병의 모든 것\">폐사율 100%, 아프리카돼지열병의 모든 것</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6010' , this);\" style=\"width: 100%;\" title=\"인삼보다 좋다는 가을무의 영양 과학\">인삼보다 좋다는 가을무의 영양 과학</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6009' , this);\" style=\"width: 100%;\" title=\"현실과 소통하는 가상 세계, 디지털 트윈이 뜬다!\">현실과 소통하는 가상 세계, 디지털 트윈이 뜬다!</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('6006' , this);\" style=\"width: 100%;\" title=\"소금의 두 얼굴\">소금의 두 얼굴</a>, <a class=\"trend_tab_btn\" data-type=\"ITREND\" href=\"javascript:void(0);\">아이콘</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201911001', this);\" style=\"width: 100%;\">WHO, 국제연합기구 중 처음으로 cOAlition S 참여</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910011', this);\" style=\"width: 100%;\">스웨덴왕립도서관(NLS), 오픈액세스에 대한 교육용 동영상 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910009', this);\" style=\"width: 100%;\">SPARC, 2018-2019 교육자료공개(OER) 현황보고서 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910010', this);\" style=\"width: 100%;\">일본 NAIST 도서관, 오픈액세스 정책 발표</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910008', this);\" style=\"width: 100%;\">DEAL 프로젝트와 Springer Nature, OA 계약에 관한 MoU 체결</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910004', this);\" style=\"width: 100%;\">COS, 교육학 분야의 프리프린트 서비스 `EdArXiv`를 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910006', this);\" style=\"width: 100%;\">OA 구축에 대한 요구사항과 원칙을 정리한 백서</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910007', this);\" style=\"width: 100%;\">OA 출판 서비스 및 비용의 투명성 제고를 위한 프레임 워크 구축</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910002', this);\" style=\"width: 100%;\">Wiley, 미국 버지니아 연구도서관 컨소시엄과 OA 출판에 관한 계약 체결</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201910001', this);\" style=\"width: 100%;\">NARCIS에 공개된 OA 출판물, 70만건 돌파</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201909005', this);\" style=\"width: 100%;\">세계 리포지터리 순위 공개(2019년 7월 기준)</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201909003', this);\" style=\"width: 100%;\">홋카이도 대학교 도서관, 오픈액세스 정책 발표</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201909002', this);\" style=\"width: 100%;\">NIH, figshare와 제휴하여 데이터 리포지터리 `NIH Figshare` 런칭</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201909001', this);\" style=\"width: 100%;\">2019 국제 오픈액세스 주간 테마 : `Open for Whom? Equity in Open Knowledge`</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908021', this);\" style=\"width: 100%;\">Taylor &amp; Francis, SDGs Online 플랫폼 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908022', this);\" style=\"width: 100%;\">오스트리아, ORCID 컨소시엄 설립</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908023', this);\" style=\"width: 100%;\">Digital Science사, 영국 연구기관의 OA에 영향을 주는 요인 발표</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908019', this);\" style=\"width: 100%;\">RDA와 COAR, 연구 데이터 관리의 국제적인 발전을 위한 협력 발표</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908020', this);\" style=\"width: 100%;\">케임브리지대학출판사(CUP), 오픈리서치 플랫폼 `Cambridge Open Engage` 발표</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908018', this);\" style=\"width: 100%;\">오픈액세스와 Plan S에 대한 학회의 대응 및 비즈니스 모델</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908015', this);\" style=\"width: 100%;\">cOAlition S, Plan S 실현을 위한  9가지 우선 순위 공개</a>, <a class=\"txt\" href=\"javascript:void(0);\" onclick=\"javascript:moveMainDetail('IWT201908017', this);\" style=\"width: 100%;\">arXiv, 개정된 Plan S 준수를 위한 기술적 검토사항 공표</a>, <a class=\"btn_more\" href=\"javascript:void(0);\" onclick=\"fnTrendMore();\">더보기</a>, <a href=\"/ndsl/member/mberuseeStplat.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"회원가입\"><span class=\"ico_m1\"></span>회원가입</a>, <a href=\"javascript:void(0);\" onclick=\"fncIdpwSearchModal(this); return false;\" title=\"아이디/비밀번호 찾기\"><span class=\"ico_m2\"></span>아이디/비밀번호 찾기</a>, <a href=\"http://www.ntis.go.kr/issuernd/main/issueDtl.do?searchTopicNo=201911040001\" style=\"margin-top:10px;\" target=\"_blank\">그래핀</a>, <a href=\"http://www.ntis.go.kr/issuernd/main/issueDtl.do?searchTopicNo=201910290001\" target=\"_blank\">자율주행버스</a>, <a href=\"http://www.ntis.go.kr/issuernd/main/issueDtl.do?searchTopicNo=201910240001\" target=\"_blank\">인공<br>장기</br></a>, <a href=\"http://www.ntis.go.kr/issuernd/main/issueDtl.do?searchTopicNo=201911060001\" target=\"_blank\">대장암<br/>세포</a>, <a href=\"http://www.ntis.go.kr/issuernd/main/issueDtl.do?searchTopicNo=201910310001\" target=\"_blank\">방사성<br/>폐기물</a>, <a class=\"btn_more\" href=\"http://www.ntis.go.kr/issuernd/main/issueMain.do\" target=\"_blank\">더보기</a>, <a class=\"txt\" href=\"/ndsl/notice/noticeDetail.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11?seq=7818\">[제6회 Korea Data-Biz Trend] 더 나은 교육 혁신, 데이터로 답하다</a>, <a class=\"txt\" href=\"/ndsl/notice/noticeDetail.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11?seq=7778\">한국과학기술정보연구원 개원기념일(5월 20일) 휴무 안내</a>, <a class=\"txt\" href=\"/ndsl/notice/noticeDetail.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11?seq=7758\">2019년 중소기업 RnD기획 지원사업(1차)</a>, <a class=\"txt\" href=\"/ndsl/notice/noticeDetail.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11?seq=7738\">2019년 과편협 학술대회 안내</a>, <a class=\"txt\" href=\"/ndsl/notice/noticeDetail.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11?seq=7718\">중국 학술논문 베타서비스 오픈안내</a>, <a class=\"btn_more\" href=\"/ndsl/notice/noticeList.do\">더보기</a>, <a class=\"link lft\" href=\"/ndsl/about/intrcn/ndslIntrcn.do\">\n",
      "<img alt=\"about NDSL - 과학기술정보 서비스 플랫폼\" src=\"../../common/images/main/link_aboutndsl.png\"/>\n",
      "<span class=\"box_border\"></span>\n",
      "</a>, <a class=\"link rgt\" href=\"http://nos.ndsl.kr/\">\n",
      "<img alt=\"NOS NDSL Open Service - 과학기술분야 개방형 유통 플랫폼\" src=\"../../common/images/main/link_nos.png\"/>\n",
      "<span class=\"box_border\"></span>\n",
      "</a>, <a href=\"/ndsl/cs/csvoice/cstmrSoundMainim.do\">\n",
      "<div class=\"help_box\">\n",
      "<h2><img alt=\"NDSL고객센터(ARS)\" src=\"../../common/images/main/h2_help.png\"/></h2>\n",
      "<p class=\"txt_call\">[무료]  080-969-4114   [유료]  02-969-4114</p>\n",
      "<p class=\"txt\">운영시간 09:00 ~ 18:00  (토요일/공휴일 휴무)</p>\n",
      "<span class=\"box_border\"></span>\n",
      "</div>\n",
      "</a>, <a class=\"link_box\" href=\"javascript:void(0);\" onclick=\"javascript:fncPinLogInsert('P23', this, 'F', 'fncCurationAccount(\\'\\')'); return false;\">\n",
      "<div class=\"title_box\">\n",
      "<span class=\"ico\"></span>\n",
      "<h2 class=\"con_tit\" style=\"letter-spacing:-1px;\">PIN 서비스 바로가기</h2>\n",
      "</div>\n",
      "</a>, <a href=\"/ndsl/about/contents/article/dmstcarticleintrcn.do\"><span class=\"tit\">논문</span><span class=\"count\"><strong>96,986,377</strong>건</span></a>, <a href=\"/ndsl/about/contents/patent/patentintrcn.do\"><span class=\"tit\">특허</span><span class=\"count\"><strong>38,402,416</strong>건</span></a>, <a href=\"/ndsl/about/contents/report/reportintrcn.do\"><span class=\"tit\">보고서</span><span class=\"count\"><strong>325,865</strong>건</span></a>, <a href=\"/ndsl/about/contents/trend/trendintrcn.do\"><span class=\"tit\">동향</span><span class=\"count\"><strong>53,208</strong>건</span></a>, <a href=\"/ndsl/about/contents/journal/jrnlintrcn.do\"><span class=\"tit\">저널/프로시딩</span><span class=\"count\"><strong>388,052</strong>건</span></a>, <a href=\"/ndsl/about/contents/rsrch/rsrchmanintrcn.do\"><span class=\"tit\">연구자</span><span class=\"count\"><strong>1,132,376</strong>건</span></a>, <a href=\"/ndsl/about/contents/rrcs/rrcsintrcn.do\"><span class=\"tit\">연구기관</span><span class=\"count\"><strong>78,303</strong>건</span></a>, <a href=\"http://www.kisti.re.kr/\" target=\"_blank\" title=\"kisti한국과학기술정보연구원\">kisti</a>, <a href=\"javascript:void(0);\" onclick=\"fncUseModalOpen();return false;\" title=\"이용약관\">이용약관</a>, <a href=\"javascript:void(0);\" onclick=\"fncIndvInfoModalOpen('2_5');return false;\" title=\"개인정보처리방침\"><strong>개인정보처리방침</strong></a>, <a href=\"http://www.kisti.re.kr/intro/directions/pageView/20\" target=\"_blank\">찾아오시는길</a>, <a href=\"javascript:void(0);\" onclick=\"fncEmailModalOpen();\" title=\"이메일무단수집거부\">이메일무단수집거부</a>, <a href=\"http://www.kisti.re.kr/intro/introduce/pageView/14\" target=\"_blank\">기관소개</a>, <a href=\"http://icon.ndsl.kr/\" target=\"_blank\" title=\"정보 서비스 동향지식포털\">정보 서비스 동향지식포털</a>, <a href=\"http://nos.ndsl.kr/\" target=\"_blank\" title=\"NOS\">NDSL 오픈서비스</a>, <a href=\"http://www.koreascience.or.kr/\" target=\"_blank\" title=\"koreascience\">koreascience</a>, <a href=\"http://society.kisti.re.kr/\" target=\"_blank\" title=\"koreascience\">과학기술학회마을</a>, <a href=\"http://mirian.kisti.re.kr/\" target=\"_blank\" title=\"Mirian\">Mirian</a>, <a href=\"http://www.kesli.or.kr/\" target=\"_blank\" title=\"KESLI\">KESLI</a>, <a href=\"http://kpubs.org/\" target=\"_blank\" title=\"kpubs\">KPUBS</a>, <a href=\"http://www.reseat.re.kr/\" target=\"_blank\" title=\"ReSeat\">ReSeat</a>, <a href=\"http://www.nktech.net/\" target=\"_blank\" title=\"NK테크\">NK테크</a>, <a href=\"http://www.kosen21.org/\" target=\"_blank\" title=\"KOSEN\">KOSEN</a>, <a href=\"http://astinet.kr/\" target=\"_blank\" title=\"ASTI\">ASTI</a>, <a href=\"http://ntis.go.kr/\" target=\"_blank\" title=\"국가과학기술지식정보서비스\">국가과학기술지식정보서비스</a>, <a href=\"http://www.creativekorea.or.kr/\" target=\"_blank\" title=\"창조경제타운\">창조경제타운</a>, <a href=\"http://portal.koreascience.or.kr/index.jsp\" target=\"_blank\" title=\"KSP\">KSP</a>, <a href=\"http://www.msip.go.kr/\" target=\"_blank\" title=\"과학기술정보통신부\">과학기술정보통신부</a>, <a href=\"http://www.nl.go.kr/\" target=\"_blank\" title=\"국립중앙도서관\">국립중앙도서관</a>, <a href=\"http://www.nanet.go.kr/\" target=\"_blank\" title=\"국회도서관\">국회도서관</a>, <a href=\"http://www.kofac.re.kr/\" target=\"_blank\" title=\"한국과학창의재단\">한국과학창의재단</a>, <a href=\"http://www.riss.kr/\" target=\"_blank\" title=\"RISS한국교육학술연구원\">RISS한국교육학술연구원</a>, <a href=\"http://www.kdb.or.kr/\" target=\"_blank\" title=\"한국데이터베이스진흥원\">한국데이터베이스진흥원</a>, <a href=\"http://www.nia.or.kr/\" target=\"_blank\" title=\"NIA\">한국정보문화진흥원</a>, <a href=\"http://www.bl.uk/\" target=\"_blank\" title=\"BL\">BL</a>, <a href=\"http://cat.cisti.nrc.ca/\" target=\"_blank\" title=\"CISTI\">CISTI</a>, <a href=\"http://www.nrf.re.kr/\" target=\"_blank\" title=\"한국연구재단\">한국연구재단</a>, <a href=\"http://www.icsti.org/\" target=\"_blank\" title=\"ICSTI\">ICSTI</a>, <a href=\"http://www.istic.ac.cn/\" target=\"_blank\" title=\"ISTIC\">ISTIC</a>, <a href=\"http://www.inist.fr/\" target=\"_blank\" title=\"INIST\">INIST</a>, <a href=\"http://www.jst.go.jp\" target=\"_blank\" title=\"JST\">JST</a>, <a href=\"http://las.ac.cn/\" target=\"_blank\" title=\"LCAS\">LCAS</a>, <a href=\"http://www.narcis.info\" target=\"_blank\" title=\"NARCIS\">NARCIS</a>, <a href=\"http://www.nii.ac.jp\" target=\"_blank\" title=\"NII\">NII</a>, <a href=\"http://www.oclc.org\" target=\"_blank\" title=\"OCLC\">OCLC</a>, <a href=\"/common/images/common/ISO10002.jpg\" target=\"_blank\"><img alt=\"ISO 10002\" src=\"/common/images/common/fot_mark1_ty2.png\"><span>ISO 10002</span></img></a>, <a href=\"https://www.dqc.or.kr/quality_certification/administrative/standard/\" target=\"_blank\"><img alt=\"데이터관리인증\" src=\"/common/images/common/fot_mark4_ty2.png\"><span>데이터관리인증</span></img></a>, <a href=\"javascript:void(0);\">모바일보기</a>, <a href=\"/ndsl/member/mberuseeStplat.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"회원가입\">회원가입</a>, <a href=\"javascript:void(0);\" onclick=\"fncIdpwSearchModal(this); return false;\" title=\"ID/PW 찾기\">ID/PW 찾기</a>, <a href=\"/ndsl/myndsl/passchk.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"회원정보관리\">회원정보관리</a>, <a href=\"/ndsl/myndsl/mnDdsList.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"원문신청정보\">원문신청 정보</a>, <a href=\"/ndsl/myndsl/bkmk/interstKeywordList.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"관심사항관리\">관심사항 관리</a>, <a href=\"/ndsl/myndsl/mnBasket.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"장바구니\">장바구니 (<span style=\"font-weight: 600; color: #0059b0;\">건</span>) </a>, <a href=\"javascript:void(0);\" onclick=\"fncSelect(this,'');return false;\">전체</a>, <a href=\"javascript:void(0);\" id=\"t_scholar\" onclick=\"fncSelect(this,'scholar');return false;\">논문</a>, <a href=\"javascript:void(0);\" id=\"t_patent\" onclick=\"fncSelect(this,'patent');return false;\">특허</a>, <a href=\"javascript:void(0);\" id=\"t_report\" onclick=\"fncSelect(this,'report');return false;\">보고서</a>, <a href=\"javascript:void(0);\" id=\"t_radar\" onclick=\"fncSelect(this,'radar');return false;\">동향</a>, <a href=\"javascript:void(0);\" id=\"t_journal\" onclick=\"fncSelect(this,'journal');return false;\">저널/프로시딩</a>, <a href=\"javascript:void(0);\" id=\"t_author\" onclick=\"fncSelect(this,'author');return false;\">연구자</a>, <a href=\"javascript:void(0);\" id=\"t_organ\" onclick=\"fncSelect(this,'organ');return false;\">연구기관</a>, <a href=\"javascript:void(0);\" onclick=\"javascript:fncCurationAccount(''); return false;\" title=\"PIN(Profiling service In NDSL) 서비스 \"><span class=\"ico_ndsl ico_tmenu12 ico_new\"></span>PIN 서비스</a>, <a href=\"/ndsl/about/intrcn/ndslIntrcn.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"about\"><span class=\"ico_ndsl ico_tmenu2\"></span>About</a>, <a href=\"/ndsl/main/siteMap.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"사이트맵\"><span class=\"ico_ndsl ico_tmenu3\"></span>사이트맵</a>, <a href=\"/ndsl/cs/csvoice/cstmrSoundMainim.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"고객센터\"><span class=\"ico_ndsl ico_tmenu4\"></span>고객센터</a>, <a href=\"/ndsl/notice/noticeList.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"공지사항\"><span class=\"ico_ndsl ico_tmenu5\"></span>공지사항</a>, <a href=\"/ndsl/issueNdsl/issueNdslList.do;jsessionid=SqwBwdbW1jgwFAi1kRXnBOiSp5g82L5lE88FlO4EfH5oJqwpynVBuIdVTMT3v6tp.al228_servlet_engine11\" title=\"이슈&amp;NDSL\"><span class=\"ico_ndsl ico_tmenu6\"></span>이슈&amp;NDSL</a>, <a href=\"http://scent.ndsl.kr\" target=\"_blank\" title=\"과학향기\"><span class=\"ico_ndsl ico_tmenu7\"></span>과학향기</a>, <a href=\"http://icon.ndsl.kr\" target=\"_blank\" title=\"iCON\"><span class=\"ico_ndsl ico_tmenu9\"></span>iCON</a>, <a href=\"javascript:void(0);\" onclick=\"fncDBStatusOpen(); return false;\" title=\"DB현황\"><span class=\"ico_ndsl ico_tmenu8\"></span>DB현황</a>, <a href=\"javascript:void(0);\" onclick=\"fncGoKardUrl(); return false;\" title=\"성과물관리\"><span class=\"ico_ndsl ico_tmenu11 ico_new\"></span>내 성과물관리</a>, <a class=\"bx-pager-link\" data-slide-index=\"0\" href=\"javascript:void(0);\">추천콘텐츠</a>, <a class=\"bx-pager-link\" data-slide-index=\"1\" href=\"javascript:void(0);\">이용현황 및 접속이력</a>, <a class=\"bx-pager-link\" data-slide-index=\"2\" href=\"javascript:void(0);\">히스토리</a>, <a class=\"bx-pager-link\" data-slide-index=\"3\" href=\"javascript:void(0);\">관심키워드</a>, <a class=\"bx-pager-link\" data-slide-index=\"4\" href=\"javascript:void(0);\">서비스 페이지</a>, <a data-slide-index=\"0\" href=\"javascript:void(0);\">추천콘텐츠<span class=\"ico_arr\"></span></a>, <a data-slide-index=\"1\" href=\"javascript:void(0);\">이용현황 및 접속이력<span class=\"ico_arr\"></span></a>, <a data-slide-index=\"2\" href=\"javascript:void(0);\">히스토리<span class=\"ico_arr\"></span></a>, <a data-slide-index=\"3\" href=\"javascript:void(0);\">관심키워드<span class=\"ico_arr\"></span></a>, <a data-slide-index=\"4\" href=\"javascript:void(0);\">서비스 페이지<span class=\"ico_arr\"></span></a>, <a class=\"alink\" href=\"https://scienceon.kisti.re.kr\" style=\"text-decoration: underline; color: dodgerblue; font-weight: 500; font-size: 13px;\" target=\"_blank\">ScienceON 알아보기</a>, <a href=\"https://scienceon.kisti.re.kr/main/personInfo.do\" target=\"_blank\"><span style=\"color: #003879; font-weight: bold\">ㆍ Science<span style=\"color:red\">ON</span></span> 개인정보처리방침(새창 열림)</a>, <a href=\"https://scienceon.kisti.re.kr/main/useInfo.do\" target=\"_blank\"><span style=\"color: #003879; font-weight: bold\">ㆍ Science<span style=\"color:red\">ON</span></span> 약관보기(새창 열림)</a>, <a class=\"abtn\" id=\"btnScienceJoin\" onclick=\"fncSciJoin('new');\" style=\"display: inline-block; margin: 10px; padding: 5px 30px; border: 2px solid red; border-radius: 3px; font-size: 16px; font-weight: 500; color: #fff; background: red; box-shadow: 0 2px 1px rgba(0, 0, 0, .4); cursor: pointer;\">회원가입</a>, <a class=\"alink\" href=\"https://scienceon.kisti.re.kr\" style=\"text-decoration: underline; color: dodgerblue; font-weight: 500; font-size: 13px;\" target=\"_blank\">ScienceON 알아보기</a>, <a class=\"abtn\" onclick=\"fncSciJoin('link');\" style=\"display: inline-block; margin: 10px; padding: 5px 30px; border: 2px solid red; border-radius: 3px; font-size: 16px; font-weight: 500; color: #fff; background: red; box-shadow: 0 2px 1px rgba(0, 0, 0, .4); cursor: pointer;\">확인</a>]\n"
     ]
    }
   ],
   "source": [
    "### [<a class=\"sister\" href=\"http://example.com/elsie\" id=\"link1\">Elsie</a>,\n",
    "###  <a class=\"sister\" href=\"http://example.com/lacie\" id=\"link2\">Lacie</a>,\n",
    "###  <a class=\"sister\" href=\"http://example.com/tillie\" id=\"link3\">Tillie</a>]\n",
    "print(soup.find_all('a'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "None\n"
     ]
    }
   ],
   "source": [
    "### <a class=\"sister\" href=\"http://example.com/tillie\" id=\"link3\">Tillie</a>\n",
    "print(soup.find(id=\"link3\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "#for link in soup.find_all('a'):\n",
    "    #print(link.get('href'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "#print(soup.get_text())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[<body class=\"article\">\n",
       " <div class=\"grid\">\n",
       " <div class=\"col twelve_col nomargin shadow\">\n",
       " <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n",
       " <div class=\"sysmessages\">\n",
       " <noscript>\n",
       " <p class=\"nojs\">\n",
       " <strong>Warning:</strong>\n",
       " \tThe NCBI web site requires JavaScript to function. \n",
       " \t<a href=\"/guide/browsers/#enablejs\" target=\"_blank\" title=\"Learn how to enable JavaScript\">more...</a>\n",
       " </p>\n",
       " </noscript>\n",
       " </div>\n",
       " <!--/.sysmessage-->\n",
       " <div class=\"wrap\">\n",
       " <div class=\"page\">\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!--/.page-->\n",
       " </div>\n",
       " <!--/.wrap-->\n",
       " </div><!-- /.twelve_col -->\n",
       " </div>\n",
       " <!-- /.grid -->\n",
       " <span class=\"PAFAppResources\"></span>\n",
       " <!-- BESelector tab -->\n",
       " <noscript><img alt=\"statistics\" src=\"/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=annalderma&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5762458/&amp;ncbi_app=pmc\"/></noscript>\n",
       " <!-- usually for JS scripts at page bottom -->\n",
       " <!--<component id=\"PageFixtures\" label=\"styles\"></component>-->\n",
       " <!-- CE89173EDC4F7321_0429SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n",
       " <script snapshot=\"pmc\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js\" type=\"text/javascript\"></script></body>,\n",
       " <div class=\"grid\">\n",
       " <div class=\"col twelve_col nomargin shadow\">\n",
       " <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n",
       " <div class=\"sysmessages\">\n",
       " <noscript>\n",
       " <p class=\"nojs\">\n",
       " <strong>Warning:</strong>\n",
       " \tThe NCBI web site requires JavaScript to function. \n",
       " \t<a href=\"/guide/browsers/#enablejs\" target=\"_blank\" title=\"Learn how to enable JavaScript\">more...</a>\n",
       " </p>\n",
       " </noscript>\n",
       " </div>\n",
       " <!--/.sysmessage-->\n",
       " <div class=\"wrap\">\n",
       " <div class=\"page\">\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!--/.page-->\n",
       " </div>\n",
       " <!--/.wrap-->\n",
       " </div><!-- /.twelve_col -->\n",
       " </div>,\n",
       " <div class=\"col twelve_col nomargin shadow\">\n",
       " <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n",
       " <div class=\"sysmessages\">\n",
       " <noscript>\n",
       " <p class=\"nojs\">\n",
       " <strong>Warning:</strong>\n",
       " \tThe NCBI web site requires JavaScript to function. \n",
       " \t<a href=\"/guide/browsers/#enablejs\" target=\"_blank\" title=\"Learn how to enable JavaScript\">more...</a>\n",
       " </p>\n",
       " </noscript>\n",
       " </div>\n",
       " <!--/.sysmessage-->\n",
       " <div class=\"wrap\">\n",
       " <div class=\"page\">\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!--/.page-->\n",
       " </div>\n",
       " <!--/.wrap-->\n",
       " </div>,\n",
       " <div class=\"sysmessages\">\n",
       " <noscript>\n",
       " <p class=\"nojs\">\n",
       " <strong>Warning:</strong>\n",
       " \tThe NCBI web site requires JavaScript to function. \n",
       " \t<a href=\"/guide/browsers/#enablejs\" target=\"_blank\" title=\"Learn how to enable JavaScript\">more...</a>\n",
       " </p>\n",
       " </noscript>\n",
       " </div>,\n",
       " <p class=\"nojs\">\n",
       " <strong>Warning:</strong>\n",
       " \tThe NCBI web site requires JavaScript to function. \n",
       " \t<a href=\"/guide/browsers/#enablejs\" target=\"_blank\" title=\"Learn how to enable JavaScript\">more...</a>\n",
       " </p>,\n",
       " <div class=\"wrap\">\n",
       " <div class=\"page\">\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!--/.page-->\n",
       " </div>,\n",
       " <div class=\"page\">\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>\n",
       " </div>,\n",
       " <div class=\"top\">\n",
       " <div class=\"universal_header\" id=\"universal_header\"><ul class=\"inline_list jig-ncbimenu ui-ncbimenu resources_list\" id=\"navcontent\"><li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset\" id=\"resource-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a></li><li class=\"topmenu ui-helper-reset ui-ncbimenu-item-first\" id=\"all-howtos-menu\"><a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a></li><li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li></ul><div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div></div>\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>\n",
       " <!--<component id=\"Page\" label=\"headcontent\"/>-->\n",
       " </div>,\n",
       " <li class=\"ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt\"><a accesskey=\"1\" class=\"ui-ncbimenu-link-first\" href=\"/\" id=\"ncbihome\" role=\"banner\" title=\"NCBI Home\"><span class=\"offscreen_noflow\">NCBI</span><img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/></a></li>,\n",
       " <span class=\"offscreen_noflow\">NCBI</span>,\n",
       " <img alt=\"NCBI Logo\" class=\"ncbi_logo\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977\" title=\"NCBI\"/>,\n",
       " <li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"3\" href=\"#maincontent\" tabindex=\"0\" title=\"Skip to the content\">Skip to main\n",
       "                         content</a></li>,\n",
       " <li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"4\" href=\"#navcontent\" tabindex=\"0\" title=\"Skip to the navigation\">Skip to\n",
       "                         navigation</a></li>,\n",
       " <a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#resources\">Resources</a>,\n",
       " <a class=\"ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown\" href=\"/static/header_footer_ajax/submenu/#howto\">How To</a>,\n",
       " <li class=\"offscreen_noflow ui-ncbimenu-item-skip access\"><a accesskey=\"0\" href=\"/guide/browsers/#accesskeys\" tabindex=\"0\" title=\"About My NCBI Accesskeys\">About NCBI Accesskeys</a></li>,\n",
       " <div class=\"myncbi\"><span id=\"myncbiusername\" style=\"display:none\"><a href=\"/account/settings/\" id=\"mnu\" title=\"Edit account settings\"></a></span><a accesskey=\"2\" href=\"/myncbi/\" id=\"myncbi\" style=\"display:none\">My NCBI</a><a href=\"/account/\" id=\"sign_in\">Sign in to NCBI</a><a href=\"/account/signout/\" id=\"sign_out\" style=\"display:none\">Sign Out</a></div>,\n",
       " <div class=\"header\">\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>\n",
       " </div>,\n",
       " <div class=\"res_logo\">\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>\n",
       " </div>,\n",
       " <h1 class=\"img_logo\"><a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a></h1>,\n",
       " <a class=\"pmc_logo offscreen\" href=\"/pmc/\">PMC</a>,\n",
       " <div class=\"NLMLogo\">\n",
       " <a href=\"https://www.nlm.nih.gov/\" title=\"US National Library of Medicine\">US National Library of Medicine</a>\n",
       " <br/>\n",
       " <a href=\"https://www.nih.gov/\" title=\"National Institutes of Health\">National Institutes of Health</a>\n",
       " </div>,\n",
       " <div class=\"search\"><form action=\"/pmc/\" method=\"get\"><div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div></form><ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul></div>,\n",
       " <div class=\"search_form\"><label class=\"offscreen_noflow\" for=\"database\">Search database</label><select id=\"database\"><optgroup label=\"Recent\"><option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option></optgroup><optgroup label=\"All\"><option value=\"gquery\">All Databases</option><option value=\"assembly\">Assembly</option><option value=\"biocollections\">Biocollections</option><option value=\"bioproject\">BioProject</option><option value=\"biosample\">BioSample</option><option value=\"biosystems\">BioSystems</option><option value=\"books\">Books</option><option value=\"clinvar\">ClinVar</option><option value=\"cdd\">Conserved Domains</option><option value=\"gap\">dbGaP</option><option value=\"dbvar\">dbVar</option><option value=\"gene\">Gene</option><option value=\"genome\">Genome</option><option value=\"gds\">GEO DataSets</option><option value=\"geoprofiles\">GEO Profiles</option><option value=\"gtr\">GTR</option><option value=\"homologene\">HomoloGene</option><option value=\"ipg\">Identical Protein Groups</option><option value=\"medgen\">MedGen</option><option value=\"mesh\">MeSH</option><option value=\"ncbisearch\">NCBI Web Site</option><option value=\"nlmcatalog\">NLM Catalog</option><option value=\"nuccore\">Nucleotide</option><option value=\"omim\">OMIM</option><option data-ac_dict=\"pmc-search-autocomplete\" value=\"pmc\">PMC</option><option value=\"popset\">PopSet</option><option value=\"probe\">Probe</option><option value=\"protein\">Protein</option><option value=\"proteinclusters\">Protein Clusters</option><option value=\"pcassay\">PubChem BioAssay</option><option value=\"pccompound\">PubChem Compound</option><option value=\"pcsubstance\">PubChem Substance</option><option value=\"pubmed\">PubMed</option><option value=\"snp\">SNP</option><option value=\"sparcle\">Sparcle</option><option value=\"sra\">SRA</option><option value=\"structure\">Structure</option><option value=\"taxonomy\">Taxonomy</option><option value=\"toolkit\">ToolKit</option><option value=\"toolkitall\">ToolKitAll</option><option value=\"toolkitbookgh\">ToolKitBookgh</option></optgroup></select><div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div></div>,\n",
       " <label class=\"offscreen_noflow\" for=\"database\">Search database</label>,\n",
       " <option class=\"last\" data-ac_dict=\"pmc-search-autocomplete\" selected=\"selected\" value=\"pmc\">PMC</option>,\n",
       " <div class=\"nowrap\"><label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label><div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div><button class=\"button_search nowrap\" cmd=\"go\" id=\"search\" type=\"submit\">Search</button></div>,\n",
       " <label accesskey=\"/\" class=\"offscreen_noflow\" for=\"term\">Search term</label>,\n",
       " <div class=\"nowrap\"><input autocomplete=\"off\" class=\"jig-ncbiclearbutton jig-ncbiautocomplete\" data-jigconfig=\"dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'\" data-sbconfig=\"ds:'no',pjs:'no',afs:'yes'\" id=\"term\" name=\"term\" title=\"Search PMC. Use up and down arrows to choose an item from the autocomplete.\" type=\"text\" value=\"\"/></div>,\n",
       " <ul class=\"searchlinks inline_list\"><li>\n",
       " <a href=\"/pmc/advanced/\">Advanced</a>\n",
       " </li><li>\n",
       " <a href=\"/pmc/journals/\">Journal list</a>\n",
       " </li><li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li></ul>,\n",
       " <li class=\"help\">\n",
       " <a href=\"/books/NBK3825/\" target=\"_blank\">Help</a>\n",
       " </li>,\n",
       " <div class=\"content\">\n",
       " <!-- site messages -->\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>\n",
       " <!-- Custom content after all -->\n",
       " <div class=\"col8\">\n",
       " </div>\n",
       " <div class=\"col9\">\n",
       " </div>\n",
       " <script src=\"/corehtml/pmc/js/jquery.scrollTo-1.4.2.js\"></script>\n",
       " <script>\n",
       "     (function($){\n",
       "         $('.skiplink').each(function(i, item){\n",
       "             var href = $($(item).attr('href'));\n",
       "             href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus\n",
       "             $(item).on('click', function(event){\n",
       "                 event.preventDefault();\n",
       "                 $.scrollTo(href, 0, {\n",
       "                     onAfter: function(){\n",
       "                         href.focus();\n",
       "                     }\n",
       "                 });\n",
       "             });\n",
       "         });\n",
       "     })(jQuery);\n",
       " </script>\n",
       " <div id=\"body-link-poppers\"></div>\n",
       " </div>,\n",
       " <div class=\"container\">\n",
       " <div class=\"content eight_col col\" id=\"maincontent\">\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>\n",
       " <!-- Journal banner -->\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>\n",
       " <!--component id='MainPortlet' label='search-reference'/-->\n",
       " <!-- Book content -->\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>\n",
       " <!-- Book content -->\n",
       " </div>\n",
       " <div class=\"four_col col last\" id=\"rightcolumn\">\n",
       " <!-- Custom content above discovery portlets -->\n",
       " <div class=\"col6\">\n",
       " </div>\n",
       " <div xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div></div><div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>\n",
       " <div data-accid=\"PMC5762458\" data-aid=\"5762458\" data-aiid=\"5762458\" data-domain=\"annalderma\" data-domainid=\"1223\" data-iid=\"304545\" data-md5=\"e9d808a84f30ca9045f9650310e8fc6f\" data-pmid=\"29386825\" id=\"ajax-portlets\"></div>\n",
       " <!-- Custom content below discovery portlets -->\n",
       " <div class=\"col7\">\n",
       " </div>\n",
       " </div>\n",
       " </div>,\n",
       " <div class=\"navlink-box\">\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>\n",
       " </div>,\n",
       " <ul class=\"page-breadcrumbs inline_list small\"><li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li><li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li><li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li><li class=\"accid\">PMC5762458</li></ul>,\n",
       " <li class=\"journal-list\"><a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a></li>,\n",
       " <a class=\"navlink\" href=\"/pmc/journals/\">Journal List</a>,\n",
       " <li class=\"archive\"><a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a></li>,\n",
       " <a class=\"navlink\" href=\"/pmc/journals/1223/\">Ann Dermatol</a>,\n",
       " <li class=\"issue-page\"><a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a></li>,\n",
       " <a class=\"navlink\" href=\"/pmc/issues/304545/\">v.30(1); 2018 Feb</a>,\n",
       " <li class=\"accid\">PMC5762458</li>,\n",
       " <div class=\"pmc-page-banner whole_rhythm\"><div><img alt=\"Logo of annalderma\" src=\"/corehtml/pmc/pmcgifs/logo-annalderma-art.gif\" usemap=\"#logo-imagemap\"/><map id=\"logo-imagemap\" name=\"logo-imagemap\"><area alt=\"This Article\" coords=\"378,29,499,43\" href=\"//dx.doi.org/10.5021/ad.2018.30.1.1\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText\" shape=\"rect\" target=\"pmc_ext\" title=\"This Article\"/><area alt=\"This Journal\" coords=\"378,29,499,43\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"This Journal\"/><area alt=\"About\" coords=\"378,15,499,29\" href=\"http://anndermatol.org/index.php?body=aims\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"About\"/><area alt=\"Information for Authors\" coords=\"378,42,500,57\" href=\"http://anndermatol.org/index.php?body=instructions\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Information for Authors\"/><area alt=\"Online Submission\" coords=\"400,56,501,78\" href=\"http://submit.anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Online Submission\"/><area alt=\"Annals of Dermatology\" coords=\"0,0,499,74\" href=\"http://anndermatol.org\" ref=\"reftype=publisher&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A\" shape=\"rect\" target=\"pmc_ext\" title=\"Annals of Dermatology\"/></map></div> </div>,\n",
       " <div class=\"\">\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>\n",
       " </div>,\n",
       " <div class=\"hide-overflow article lit-style content pmc-wm slang-all page-box\"><!--main-content--><div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div></div>,\n",
       " <div class=\"jig-ncbiinpagenav\" data-jigconfig=\"smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'\"><div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div><div class=\"sec\"></div><div class=\"tsec sec\" id=\"idm140493185853120\" lang=\"en\"><h2 class=\"head no_bottom_margin\" id=\"idm140493185853120title\">Abstract</h2><!--article-meta--><div><div class=\"sec sec-first\" id=\"__sec1\"><h3 id=\"__sec1title\">Background</h3><p class=\"p p-first-last\" id=\"__p1\">Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions.</p></div><div class=\"sec\" id=\"__sec2\"><h3 id=\"__sec2title\">Objective</h3><p class=\"p p-first-last\" id=\"__p2\">To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma.</p></div><div class=\"sec\" id=\"__sec3\"><h3 id=\"__sec3title\">Methods</h3><p class=\"p p-first-last\" id=\"__p3\">Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not.</p></div><div class=\"sec\" id=\"__sec4\"><h3 id=\"__sec4title\">Results</h3><p class=\"p p-first-last\" id=\"__p4\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment.</p></div><div class=\"sec sec-last\" id=\"__sec5\"><h3 id=\"__sec5title\">Conclusion</h3><p class=\"p p-first-last\" id=\"__p5\">PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.</p></div></div><div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div></div><div class=\"tsec sec\" id=\"__sec6\"><h2 class=\"head no_bottom_margin\" id=\"__sec6title\">INTRODUCTION</h2><p class=\"p p-first\" id=\"__p6\">Melasma is an acquired pigmentary disorder presenting brownish patches on the face, most commonly observed in females with a darker skin type. The major etiological factors are genetic influences, exposure to ultraviolet (UV) radiation, and sex hormones<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549010\" rid=\"B1\">1</a></sup>, although the exact pathogenesis of melasma is not fully elucidated. The pathophysiology of melasma is believed to involve excess production of melanin or an increase in the number of melanocytes in the skin. Laser toning using low-fluence 1,064 nm Q-switched Nd:YAG laser (QSNY) has been an effective treatment option in Asia, but monotherapy treatment efficacies were variable<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549018\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549019\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549023\" rid=\"B4\">4</a></sup>.</p><p id=\"__p7\">Recent studies have suggested that interactions between the altered cutaneous vasculature and melanocytes have an influence on hyperpigmentation development in melasma, which demonstrated that greater vascularity is one of the major findings<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B5\" id=\"__tag_659549016\" rid=\"B5\">5</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B6\" id=\"__tag_659549014\" rid=\"B6\">6</a></sup>. Based on this finding, it has been investigated whether the treatment targeting blood vessels is beneficial in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549017\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549003\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549013\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548998\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549000\" rid=\"B11\">11</a></sup>. Pulsed-dye laser (PDL) is considered a gold standard laser therapy for cutaneous vascular lesions, which has been shown to be an effective treatment option in combination with pigment-targeted modalities for melasma patients in several studies<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549007\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659549020\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549030\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549002\" rid=\"B10\">10</a></sup>. Also, it has been reported that the copper bromide laser, oral and topical tranexamic acid are effective in the treatment of melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549033\" rid=\"B7\">7</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B8\" id=\"__tag_659548997\" rid=\"B8\">8</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548999\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659549008\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549034\" rid=\"B11\">11</a></sup>.</p><p class=\"p p-last\" id=\"__p8\">Dermoscopy is a useful tool for detecting clinically invisible or neglectable vessel changes effectively. We thought these findings may be helpful for the candidate selection for treatment including vascular-target therapy. Several studies have been reported the effect of PDL in melasma treatment, but there has been no comparative study on the therapeutic effect of PDL between melasma patients who show dermoscopic finding of visibly widened capillaries and who do not. Therefore, this study was conducted to investigate whether PDL provides additional improvements when combined with QSNY for melasma treatment, using dermoscopy to find subtle vascular structures and evaluated whether these findings showed differences.</p></div><div class=\"tsec sec\" id=\"__sec7\"><h2 class=\"head no_bottom_margin\" id=\"__sec7title\">MATERIALS AND METHODS</h2><div class=\"sec sec-first\" id=\"__sec8\"><h3 id=\"__sec8title\">Study subjects</h3><p class=\"p p-first-last\" id=\"__p9\">We conducted a randomized, single-blind, split-face prospective study between December 2015 and April 2016. Seventeen Korean women with melasma aged 18 years or above were included in the present study. The Fitzpatrick skin type was determined for all patients. The exclusion criteria included underlying skin diseases, use of isotretinoin or contraceptive pills during the past six months, pregnancy or breastfeeding, topical bleaching agent usage within one month before recruitment, employment of chemical peels, laser therapy or intense pulsed light treatment also within six months at the study's beginng, and sunlight or UV light exposures. This clinical study was approved by the Institutional Review Board of Ulsan University Hospital (Ulsan, Korea) (IRB no. 2014-03-006) and written informed consent was obtained from all subjects.</p></div><div class=\"sec\" id=\"__sec9\"><h3 id=\"__sec9title\">Treatment methods</h3><p class=\"p p-first-last\" id=\"__p10\"><a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>. shows a schematized summary of the treatment schedule. A total of 17 patients were treated, and each side of the face was randomly allocated to either QSNY or PDL+QSNY treatment. All subjects were treated with a total of nine full-face QSNY treatment sessions (Cosjet TR®; Won Technology, Daejeon, Korea) at one-week intervals. On the PDL+QSNY side of the face, additional PDL treatments (Cynergy Multiplex™; Cynosure, Westford, MA, USA) were performed with a total of three sessions at baseline, week 4, and week 8. The patients were treated first with low-fluence QSNY on the entire face and subsequent PDL treatment was performed immediately after QSNY treatment on the half of the face with a 10% overlap of treatment spots to target the vessels. Both laser therapy were stopped when mild erythema appeared around the melasma lesion. No anesthesia was necessary prior to the treatment. The assignment to treatments was made only when a subject attended the first therapy session. Laser parameters for QSNY settings were a 1,064 nm wavelength, 7 mm spot size, and a fluence of 1.2~2.0 J/cm<sup>2</sup> at 10 Hz (five to seven passes), whereas the PDL settings were of a 595 nm wavelength, seven mm spot size, a 20-milisecond pulse duration, as well as a 7~8 J/cm<sup>2</sup> fluence (two to three passes). The patients were not allowed to use any other form of treatment or functional cosmetics and they were also instructed to avoid sun exposure and to apply a broad-spectrum sunscreen.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F1\" id=\"F1\"><a href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493180239344\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F1/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F1\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div></div></div></div><div class=\"sec\" id=\"__sec10\"><h3 id=\"__sec10title\">Efficacy assessments</h3><p class=\"p p-first\" id=\"__p11\">Before each session, one week after the last treatment (week 9), and follow-up visits after eight weeks since the last treatment (week 16), digital photographic documentation (Nikon D7000; Nikon Corporation, Tokyo, Japan) was obtained under the same conditions. Dermoscopic images were also obtained using dermoscopy equipment (X20) (DermLite II Pro; 3Gen, San Juan Capistrano, CA, USA). Calibration of the different parameters (luminosity, contrast, white balance, color balance) was performed prior to starting a series of images. To visualize vessels, the glass lens was carefully placed on the lesion; also, minimal pressure was applied. Based on the fact whether the visibly widened capillaries were detected or not in dermoscopic images, estimations were made. Two independent dermatologists evaluated the melasma area and severity index (MASI) scores, using the photographs taken at baseline, week 9 and 16. The mean value of the data obtained from each half of the face was calculated and the mean percentage change was compared. Hemi-MASI score was used because of the study design of split-face, and it was calculated based on the percentage of the involved area (A=0~6: 0=0%, 1=1%~9%, 2=10%~29%, 3=30%~49%, 4=50%~69%, 5=70%~89%, 6=90%~100%), darkness of pigment (D=0~4: 0=absent or normal skin color without evidence of hyperpigmentation, 1=slight visible hyperpigmentation, 2=mild visible, 3=marked, 4=severe), and homogenicity of the hyperpigmentation (H=0~4: 0=minimal, 1=slight, 2=mild, 3=marked, 4=severe).</p><p class=\"p p-last\" id=\"__p12\">Hemi-MASI score=forehead, 0.15×(D+H)×A+malar, 0.30×(D+H)×A+chin, 0.05×(D+H)×A.</p></div><div class=\"sec\" id=\"__sec11\"><h3 id=\"__sec11title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p13\">At each follow-up visit, adverse events were also evaluated. Patients were asked to reports side effects such as erythema, burning, swelling, blistering, crust, hyperpigmentation or hypopigmentation, atrophy, and others during and after treatment. The dermatologist categorized the degree of erythema and burning into four grades: none, mild, moderate, and severe.</p></div><div class=\"sec sec-last\" id=\"__sec12\"><h3 id=\"__sec12title\">Statistical analysis</h3><p class=\"p p-first-last\" id=\"__p14\">All analyses were performed using SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA). Continuous variables were described as means and standard deviations (SD). Data were analyzed using Mann-Whitney U-test. <em>p</em>&lt;0.05 was considered statistically significant.</p></div></div><div class=\"tsec sec\" id=\"__sec13\"><h2 class=\"head no_bottom_margin\" id=\"__sec13title\">RESULTS</h2><div class=\"sec sec-first\" id=\"__sec14\"><h3 id=\"__sec14title\">Demographics</h3><p class=\"p p-first-last\" id=\"__p15\">Seventeen melasma patients were enrolled in this study. The Fitzpatrick skin type was III in eight, IV in five patients, and V in four patients. The mean age was 41 years (range, 31~53 years). The disease duration ranged from 3 to 15 years (mean±SD, 12.47±5.62 years).</p></div><div class=\"sec\" id=\"__sec15\"><h3 id=\"__sec15title\">Treatment efficacy assessments</h3><p class=\"p p-first-last\" id=\"__p16\">MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>). Among 17 patients, seven (41.2%) showed visibly widened capillaries in dermoscopic images (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>) whose MASI scores of both PDL+QSNY and QSNY sides were decreased significantly during the study period. These patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>). However, patients who did not show visibly widened capillaries showed no significant difference in the MASI score change between both sides (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>). <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a> illustrated the clinical appearance of one case among the seven patients; this subject showed visibly widened capillaries in dermoscopic images at baseline.</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F2\" id=\"F2\"><a href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493261952192\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F2/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F2\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F3\" id=\"F3\"><a href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493189285840\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F3/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F3\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T1\"><h3>Table 1</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493260912944\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T1/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T2\"><h3>Table 2</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493179066064\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T2/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div><!--table ft1--><!--table-wrap mode=\"anchored\" t5--><div class=\"table-wrap table anchored whole_rhythm\" id=\"T3\"><h3>Table 3</h3><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div><div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493177562736\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/table/T3/?report=objectonly\" target=\"object\">Open in a separate window</a></div><div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div></div></div><div class=\"sec sec-last\" id=\"__sec16\"><h3 id=\"__sec16title\">Safety assessments</h3><p class=\"p p-first-last\" id=\"__p17\">A majority of the patients had a mild burning sensation tolerable during laser therapy. A mild erythema was observed after the treatment, lasting for approximately one to two hours in most patients. Pigmentary adverse events associated with the PDL+QSNY side were observed in two out of 17 subjects. One patient whose Fitzpatrick skin type was IV showed focal purpura observed in the PDL+QSNY side at the last treatment, which disappeared spontaneously after 1 week. Postinflammatory hyperpigmentation (PIH) developed after two months since the last treatment. Another patient whose Fitzpatrick skin type was V exhibited a rebound hyperpigmentation (RH) without purpura on PDL+QSNY side at the follow-up visit after 8 weeks since the last treatment (<a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class=\"fig iconblock whole_rhythm clearfix\" co-legend-rid=\"lgnd_F4\" id=\"F4\"><a href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><!--fig/graphic|fig/alternatives/graphic mode=\"anchored\" m1--><div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div><div class=\"largeobj-link align_right\" id=\"largeobj_idm140493176804832\" style=\"display: none\"><a href=\"/pmc/articles/PMC5762458/figure/F4/?report=objectonly\" target=\"object\">Open in a separate window</a></div></a><div class=\"icnblk_cntnt\" id=\"lgnd_F4\"><div><a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a></div><!--caption a7--><div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div></div></div></div></div><div class=\"tsec sec\" id=\"__sec17\"><h2 class=\"head no_bottom_margin\" id=\"__sec17title\">DISCUSSION</h2><p class=\"p p-first\" id=\"__p18\">Melasma is a chronic distressing condition and often therapeutically challenging. Various treatments, including whitening or bleaching agents (e.g., hydroquinone, azelaic acid), chemical peels (e.g., glycolic, β-hydroxyl, and trichloroacetic acids), topical steroids, as well as laser treatment demonstrated some therapeutic effect but were often unsuccessful with regard to refractory melasma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B12\" id=\"__tag_659549015\" rid=\"B12\">12</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B13\" id=\"__tag_659549028\" rid=\"B13\">13</a></sup>. A large-spot-size, low-energy-mode of the 1,064 nm QSNY is a popular method of melasma therapy in Asia. The QSNY has a longer wavelength that can penetrate deeper to target both mixed and dermal melasma. It can also target lesional melanocytes and causes of subcellular damage to its melanin particles precisely<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B14\" id=\"__tag_659549032\" rid=\"B14\">14</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B15\" id=\"__tag_659549031\" rid=\"B15\">15</a></sup>. Moreover, QSNY may also produce nonspecific dermal wounds and induce inflammation, facilitating a migration of melanophages<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B16\" id=\"__tag_659548993\" rid=\"B16\">16</a></sup>. However, these effects were transient and reversible, with a high recurrence rate<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659549011\" rid=\"B9\">9</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B10\" id=\"__tag_659548996\" rid=\"B10\">10</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B11\" id=\"__tag_659549029\" rid=\"B11\">11</a></sup>.</p><p id=\"__p19\">The pathogenesis of melasma is not completely understood, which renders treatment more complicated. There are many possible contributing factors which include genetic influences, exposure to UV radiation, female sex hormones, thyroid dysfunction, cosmetics, and drugs<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B1\" id=\"__tag_659549021\" rid=\"B1\">1</a></sup>. Although the cause of melasma has not been fully comprehended, it has recently been suggested that vascular endothelial growth factor (VEGF) and skin vascularization might play a role in the melasma pigmentation<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659548995\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549001\" rid=\"B3\">3</a></sup>. Human melanocytes may respond to angiogenic factors because normal human melanocytes show functional VEGF receptors. Therefore, VEGF may have a direct influence on melanocyte behavior through its receptors<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549004\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659548992\" rid=\"B3\">3</a></sup>. It is also known to stimulate the release of arachidonic acid as well as the phosphorylation and activation of cytosolic phospholipase A2. It is possible that the resulting metabolites from the arachidonic acid pathway affect melanogenesis<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549009\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549005\" rid=\"B3\">3</a></sup>.</p><p id=\"__p20\">Cho et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549006\" rid=\"B2\">2</a></sup> reported that only the area affected by melasma presents a pronounced vascular change, showing significant increases in the number and size of dermal blood vessels. Moreover, they considered that the number of vessels is positively related to the degree of pigmentation. Park et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549012\" rid=\"B17\">17</a></sup> demonstrated that the degree of erythema is positively correlated with that of pigmentation in a melasma lesion. Thus, vascularity increases may play an important role in the melasma pathogenesis and the cause of PIH after laser therapy by an increase of cytokines and soluble factors released from proliferated vessels<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B17\" id=\"__tag_659549022\" rid=\"B17\">17</a></sup>. </p><p id=\"__p21\">From this point of view, laser targeting blood vessel might decrease the stimulation of melanocytes and prevent relapse. PDL targets oxyhemoglobin within cutaneous vasculatures and it has been widely employed to treat diverse vascular disorders. By targeting not only melanin but also vascularization, PDL might provide—in combination with QSNY—an effective and successful therapeutic approach for melasma.</p><p id=\"__p22\">In our split-face study, the MASI scores of both sides decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. Some of the patients exhibited a greater improvement and all of them had visibly widened capillaries on dermoscopic image. These seven patients showed significant difference in both sides in terms of changes in the MASI score during treatment (<em>p</em>=0.026).</p><p id=\"__p23\">It is reasonable to assume that the efficacy of PDL+QSNY is greater in a melasma with obvious vascular lesions. Moreover, not only the PDL+QSNY reveals an effectiveness in MASI score reduction of during the treatment period, but there was also a tendency for relapse prevention after treatment, while only-side QSNY revealed an increase of the MASI score during the follow-up period.</p><p id=\"__p24\">Laser parameter settings for low fluence QSNY are relatively well established in the Asian melasma treatments. However, in most previous studies which used QSNY at 2.5~4.0 J/cm<sup>2</sup>, there were adverse events such as postinflammatory hypopigmentation and punctate leukoderma<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B2\" id=\"__tag_659549025\" rid=\"B2\">2</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B3\" id=\"__tag_659549027\" rid=\"B3\">3</a></sup><sup>,<a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B4\" id=\"__tag_659549024\" rid=\"B4\">4</a></sup>. Thus, we used lower fluence of 1.2~2.0 J/cm<sup>2</sup> than previous studies to minimize the possibility of these unwanted outcomes.</p><p id=\"__p25\">Geddes et al.<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B7\" id=\"__tag_659549026\" rid=\"B7\">7</a></sup> and Passeron<sup><a class=\"bibr popnode tag_hotlink tag_tooltip\" href=\"#B9\" id=\"__tag_659548994\" rid=\"B9\">9</a></sup> investigated the effect of vascular targeted therapy of melasma and they chose PDL setting as energy fluence of 7.5~8 J/cm<sup>2</sup> and 10 J/cm<sup>2</sup>, respectively. These laser settings were chosen to minimize thermal damage and risk of rebound melasma. In addition to these studies, in our preliminary study for determining the parameter of PDL, we observed several cases of purpura after PDL treatment using short pulse width. Thus, we used long pulse width to prevent purpura. Also, we assumed that even though ten patients did not show vascular prominence at dermoscopy finding, they may get subclinical improvement after PDL treatment. Indeed, PDL+QSNY treatment reduced MASI scores of the lesion among these 10 patients (<a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>).</p><p id=\"__p26\">Even with our conservative PDL parameters (7 mm spot size, a 20-millisecond pulse duration, and a fluence of 7~8 J/cm<sup>2</sup>), two patients who both had visibly widened capillaries on dermoscopic images presented with adverse effects such as PIH and RH. Hence, an increase in vascularity may be potentially associated with increased inflammatory cytokines and enhanced melanogenesis. Along with excessive cumulative laser energy of PDL+QSNY, this might be a factor with regard to adverse effects such as PIH and RH in our study.</p><p id=\"__p27\">We judge that it can be difficult to clinically find a capillary underlying the melasma lesions. Dermoscopy aids in the visualization of the epidermis and dermis, which is usually used to diagnose pigmented lesions. Recently, it has also increasingly been used to find vascular lesions. The skin's structure can be observed on an enlarged scale, which helps effectively in identifying even subtle vascular structures. We used dermoscopy to detect subtle telangiectasia within melasma lesions. This may also allow the best candidates' selection for the addition of a vascular-targeted therapy and for monitoring a patient's treatment progress.</p><p id=\"__p28\">The study limitations included its small sample size and a relatively short follow-up period. Melasma relapses are common after a certain period despite proper treatments. We could not evaluate long-term results of efficacy in our melasma patients. Additionally, the characteristics of the split-face study make it difficult to detect improvement.</p><p class=\"p p-last\" id=\"__p29\">In conclusion, PDL combined with QSNY may be considered as an effective treatment for melasma patients who show visibly widened capillaries on dermoscopy. By targeting the vascular lesions in melasma, PDL may partially inhibit melanocyte activation. These findings could provide physicians with a melasma treatment concept, targeting multiple components. We believe that additional PDL treatment can be effective in managing melasma with a telangiectatic component. Also, dermoscopy may be a helpful diagnostic tool for the candidate selection for PDL treatment. Further prospectively oriented research with additional subjects, skin types, and a long-term follow-up is needed.</p></div><div class=\"tsec sec\" id=\"idm140493176531488\"><h2 class=\"head no_bottom_margin\" id=\"idm140493176531488title\">Footnotes</h2><!--back/fn-group--><div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div></div><div class=\"tsec sec\" id=\"idm140493261384064\"><h2 class=\"head no_bottom_margin\" id=\"idm140493261384064title\">References</h2><div class=\"ref-list-sec sec\" id=\"reference-list\"><div class=\"ref-cit-blk half_rhythm\" id=\"B1\">1. <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B2\">2. <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B3\">3. <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B4\">4. <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B5\">5. <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B6\">6. <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B7\">7. <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B8\">8. <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B9\">9. <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B10\">10. <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B11\">11. <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B12\">12. <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B13\">13. <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B14\">14. <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B15\">15. <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B16\">16. <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div><div class=\"ref-cit-blk half_rhythm\" id=\"B17\">17. <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span></div></div></div></div>,\n",
       " <div class=\"fm-sec half_rhythm no_top_margin\"><div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div><h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1><div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div><div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div class=\"links-box whole_rhythm\" id=\"pmclinksbox\"><div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div></div></div>,\n",
       " <div class=\"fm-citation half_rhythm no_top_margin clearfix\"><div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div><div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div></div>,\n",
       " <div class=\"inline_block eight_col va_top\"><div><div><span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span></div><div><span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span> <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span></div></div></div>,\n",
       " <span class=\"cit\"><span id=\"pmcmata\">Ann Dermatol</span>. 2018 Feb; 30(1): 1–7. </span>,\n",
       " <span class=\"fm-vol-iss-date\">Published online 2017 Dec 26. </span>,\n",
       " <span class=\"doi\">doi: <a href=\"//dx.doi.org/10.5021%2Fad.2018.30.1.1\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI\" target=\"pmc_ext\">10.5021/ad.2018.30.1.1</a></span>,\n",
       " <div class=\"inline_block four_col va_top show-overflow align_right\"><div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div></div>,\n",
       " <div class=\"fm-citation-ids\"><div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div><div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div></div>,\n",
       " <div class=\"fm-citation-pmcid\"><span class=\"fm-citation-ids-label\">PMCID: </span><span>PMC5762458</span></div>,\n",
       " <span class=\"fm-citation-ids-label\">PMCID: </span>,\n",
       " <div class=\"fm-citation-pmid\">PMID: <a href=\"/pubmed/29386825\">29386825</a></div>,\n",
       " <h1 class=\"content-title\">Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study</h1>,\n",
       " <div class=\"half_rhythm\"><div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div><div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div></div>,\n",
       " <div class=\"contrib-group fm-author\"><a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,<sup></sup> <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,<sup></sup> and  <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup><sup></sup></div>,\n",
       " <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493227082368\" href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a>,\n",
       " <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493186870176\" href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a>,\n",
       " <a class=\"affpopup\" co-class=\"co-affbox\" co-rid=\"_co_idm140493180900480\" href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a>,\n",
       " <div class=\"contrib-group aff-tip\" style=\"display:none\"><div id=\"_co_idm140493227082368\"><h3 class=\"no_margin\">Sook Hyun Kong</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Kong%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Sook Hyun Kong</a></div></div><div id=\"_co_idm140493186870176\"><h3 class=\"no_margin\">Ho Seok Suh</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Suh%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Ho Seok Suh</a></div></div><div id=\"_co_idm140493180900480\"><h3 class=\"no_margin\">Yu Sung Choi</h3><p>Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</p><div>Find articles by <a href=\"/pubmed/?term=Choi%20YS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29386825\">Yu Sung Choi</a></div></div></div>,\n",
       " <h3 class=\"no_margin\">Sook Hyun Kong</h3>,\n",
       " <h3 class=\"no_margin\">Ho Seok Suh</h3>,\n",
       " <h3 class=\"no_margin\">Yu Sung Choi</h3>,\n",
       " <div class=\"fm-panel half_rhythm\"><div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div><div class=\"fm-authors-info fm-panel hide half_rhythm\" id=\"idm140493192655008_ai\" style=\"display:none\"><div class=\"fm-affl\" id=\"A1\" lang=\"en\">Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.</div><div><sup><img alt=\"corresponding author\" src=\"/corehtml/pmc/pmcgifs/corrauth.gif\"/></sup>Corresponding author.</div><div id=\"idm140493179846992\"> Corresponding author: Yu Sung Choi. Department of Dermatology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea. Tel: 82-52-250-7090, Fax: 82-52-250-7155, <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a></div></div><div class=\"fm-article-notes fm-panel hide half_rhythm\" id=\"idm140493192655008_an\" style=\"display:none\"><div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div></div><div class=\"permissions fm-panel half_rhythm hide\" id=\"idm140493192655008_cpl\" style=\"display:none\"><div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div><div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div>,\n",
       " <div class=\"togglers\"><a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a> <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a> <a href=\"/pmc/about/disclaimer/\">Disclaimer</a></div>,\n",
       " <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_ai\">Author information</a>,\n",
       " <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_an\">Article notes</a>,\n",
       " <a class=\"pmctoggle\" href=\"#\" rid=\"idm140493192655008_cpl\">Copyright and License information</a>,\n",
       " <a class=\"oemail\" data-email=\"ten.muad@amredhuu\" href=\"mailto:dev@null\">ten.muad@amredhuu</a>,\n",
       " <div class=\"fm-pubdate half_rhythm\">Received 2016 Dec 12; Revised 2017 Mar 23; Accepted 2017 Apr 18.</div>,\n",
       " <div class=\"fm-copyright half_rhythm\"><a href=\"/pmc/about/copyright/\">Copyright</a>  © 2018 The Korean Dermatological Association and The Korean Society for Investigative Dermatology</div>,\n",
       " <div class=\"license half_rhythm\">This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a data-ga-action=\"click_feat_suppl\" href=\"http://creativecommons.org/licenses/by-nc/4.0\" ref=\"reftype=extlink&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI\" target=\"_blank\">http://creativecommons.org/licenses/by-nc/4.0</a>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</div>,\n",
       " <div class=\"fm-panel\"><div>This article has been <a href=\"/pmc/articles/PMC5762458/citedby/\">cited by</a> other articles in PMC.</div></div>,\n",
       " <div class=\"sec\"></div>,\n",
       " <div class=\"sec\"><strong class=\"kwd-title\">Keywords: </strong><span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span></div>,\n",
       " <strong class=\"kwd-title\">Keywords: </strong>,\n",
       " <span class=\"kwd-text\">Dermoscopy, Melasma, Pulsed dye lasers, Q-switched lasers</span>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F1\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\"><span>Fig. 1</span></a>,\n",
       " <div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493180239344\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a></div>,\n",
       " <a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g001.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/></a>,\n",
       " <div class=\"ts_bar small\" title=\"Click on image to zoom\"></div>,\n",
       " <img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g001.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g001.jpg\" title=\"Click on image to zoom\"/>,\n",
       " <a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F1/\" rid-figpopup=\"F1\" rid-ob=\"ob-F1\" target=\"figure\">Fig. 1</a>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>Schematized summary of treatment schedule. PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</strong></div>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T1/\" rid-figpopup=\"T1\" rid-ob=\"ob-T1\" target=\"table\"><span>Table 1</span></a>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F2\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\"><span>Fig. 2</span></a>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T2/\" rid-figpopup=\"T2\" rid-ob=\"ob-T2\" target=\"table\"><span>Table 2</span></a>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F3\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\"><span>Fig. 3</span></a>,\n",
       " <div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493261952192\"><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/></div>,\n",
       " <img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\" class=\"fig-image\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g002.jpg\" title=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g002.jpg\"/>,\n",
       " <a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F2/\" rid-figpopup=\"F2\" rid-ob=\"ob-F2\" target=\"figure\">Fig. 2</a>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>Dermoscopic image of a patient who showed visibly widened capillaries along with pigmentation of a pseudonetwork pattern at the first visit.</strong></div>,\n",
       " <div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493189285840\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a></div>,\n",
       " <a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g003.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/></a>,\n",
       " <div class=\"ts_bar small\" title=\"Click on image to zoom\"></div>,\n",
       " <img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g003.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g003.jpg\" title=\"Click on image to zoom\"/>,\n",
       " <a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F3/\" rid-figpopup=\"F3\" rid-ob=\"ob-F3\" target=\"figure\">Fig. 3</a>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>Serial clinical photographs of a melasma patient with visibly widened capillaries on dermoscopy. Comparing the melasma area and severity index (MASI) score reduction from the baseline, pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side (A, B, and C) revealed a significantly greater reduction of the MASI scores at week 9 and 16 than the QSNY side (D, E, and F). The PDL+QSNY side maintained a MASI score reduction at week 16 (C), while it increased for the QSNY side (F).</strong></div>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores during the study period (n=17)</strong></div>,\n",
       " <div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493260912944\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table></div>,\n",
       " <table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.53±2.65</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.23±2.81</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.19±2.62</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−22.1</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.30±2.63</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.5</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.231</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.07±2.58</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−24.0</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.33±2.84</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.114</td></tr></tbody></table>,\n",
       " <div class=\"tblwrap-foot\"><div id=\"idm140493184191136\"><p class=\"p p-first-last\" id=\"__p31\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who showed visibly widened capillaries on dermoscopy (n=7)</strong></div>,\n",
       " <div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493179066064\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table></div>,\n",
       " <table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.60±2.66</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.99±2.86</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.46±2.49</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−34.9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.92±2.16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−15.4</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.026</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">4.29±2.24</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−37.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.09±2.88</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−16.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.017</td></tr></tbody></table>,\n",
       " <div class=\"tblwrap-foot\"><div id=\"idm140493176646032\"><p class=\"p p-first-last\" id=\"__p32\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>The changes of the MASI scores of the patients who didn't show visibly widened capillaries on dermoscopy (n=10)</strong></div>,\n",
       " <div class=\"xtable\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493177562736\"><table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table></div>,\n",
       " <table class=\"rendered small default_table\" frame=\"hsides\" rules=\"rows\"><thead><tr><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"></th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">PDL+QSNY</th><th align=\"center\" colspan=\"2\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">QSNY</th><th align=\"center\" colspan=\"1\" rowspan=\"2\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\"><em>p</em>-value</th></tr><tr><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">MASI</th><th align=\"center\" colspan=\"1\" rowspan=\"1\" style=\"background-color:rgb(192,192,192)\" valign=\"middle\">Percentage change</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Baseline</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.48±2.80</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">6.40±2.91</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\"></td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 9</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.71±2.72</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.57±3.00</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−13.8</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.971</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Week 16</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.62±2.77</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.7</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">5.49±2.96</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">−14.3</td><td align=\"center\" colspan=\"1\" rowspan=\"1\" valign=\"top\">0.853</td></tr></tbody></table>,\n",
       " <div class=\"tblwrap-foot\"><div id=\"idm140493177205200\"><p class=\"p p-first-last\" id=\"__p33\">Values are presented as mean±standard deviation or percentage. MASI: melasma area and the severity index, PDL: pulsed-dye laser, QSNY: Q-switched Nd:YAG laser.</p></div></div>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"lgnd_F4\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\"><span>Fig. 4</span></a>,\n",
       " <div class=\"figure\" data-largeobj=\"\" data-largeobj-link-rid=\"largeobj_idm140493176804832\"><a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a></div>,\n",
       " <a class=\"inline_block ts_canvas\" href=\"/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5762458_ad-30-1-g004.jpg\" target=\"tileshopwindow\"><div class=\"ts_bar small\" title=\"Click on image to zoom\"></div><img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/></a>,\n",
       " <div class=\"ts_bar small\" title=\"Click on image to zoom\"></div>,\n",
       " <img alt=\"An external file that holds a picture, illustration, etc.\n",
       " Object name is ad-30-1-g004.jpg\" class=\"tileshop\" src=\"/pmc/articles/PMC5762458/bin/ad-30-1-g004.jpg\" title=\"Click on image to zoom\"/>,\n",
       " <a class=\"figpopup\" href=\"/pmc/articles/PMC5762458/figure/F4/\" rid-figpopup=\"F4\" rid-ob=\"ob-F4\" target=\"figure\">Fig. 4</a>,\n",
       " <div class=\"caption\"><!--caption a8--><strong>The patient who exhibited a rebound hyperpigmentation without purpura on pulsed-dye laser (PDL)+Q-switched Nd:YAG laser (QSNY) side at week 16. PDL+QSNY side (A, B, and C) revealed a great reduction of the melasma area and severity index score at week 9 (B) from the baseline (A), but rebound hyperpigmentation occurred at week 16 (C). QSNY side (D, E, and F) showed no rebound hyperpigmentation.</strong></div>,\n",
       " <a class=\"fig-table-link figpopup\" co-legend-rid=\"\" href=\"/pmc/articles/PMC5762458/table/T3/\" rid-figpopup=\"T3\" rid-ob=\"ob-T3\" target=\"table\"><span>Table 3</span></a>,\n",
       " <div class=\"fm-sec half_rhythm small\"><p class=\"fn sec\" id=\"idm140493176531360\"><p class=\"p p-first-last\" id=\"__p30\"><strong>CONFLICTS OF INTEREST:</strong> The authors have nothing to disclose.</p></p></div>,\n",
       " <span class=\"element-citation\">Grimes PE. Melasma. Etiologic and therapeutic considerations. <span><span class=\"ref-journal\">Arch Dermatol. </span>1995;<span class=\"ref-vol\">131</span>:1453–1457.</span> [<a href=\"/pubmed/7492140\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Arch Dermatol. </span>,\n",
       " <span class=\"ref-vol\">131</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma.+Etiologic+and+therapeutic+considerations&amp;author=PE+Grimes&amp;volume=131&amp;publication_year=1995&amp;pages=1453-1457&amp;pmid=7492140&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. <span><span class=\"ref-journal\">Clin Exp Dermatol. </span>2009;<span class=\"ref-vol\">34</span>:e847–e850.</span> [<a href=\"/pubmed/19817757\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Clin Exp Dermatol. </span>,\n",
       " <span class=\"ref-vol\">34</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Dermatol&amp;title=Melasma+treatment+in+Korean+women+using+a+1064-nm+Q-switched+Nd:YAG+laser+with+low+pulse+energy&amp;author=SB+Cho&amp;author=JS+Kim&amp;author=MJ+Kim&amp;volume=34&amp;publication_year=2009&amp;pages=e847-e850&amp;pmid=19817757&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:76–87.</span> [<a href=\"/pubmed/20298254\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Dermatol Surg. </span>,\n",
       " <span class=\"ref-vol\">36</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Low-fluence+Q-switched+neodymium-doped+yttrium+aluminum+garnet+(1,064+nm)+laser+for+the+treatment+of+facial+melasma+in+Asians&amp;author=P+Wattanakrai&amp;author=R+Mornchan&amp;author=S+Eimpunth&amp;volume=36&amp;publication_year=2010&amp;pages=76-87&amp;pmid=20298254&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. <span><span class=\"ref-journal\">Lasers Surg Med. </span>2010;<span class=\"ref-vol\">42</span>:712–719.</span> [<a href=\"/pubmed/20848553\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Lasers Surg Med. </span>,\n",
       " <span class=\"ref-vol\">42</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Lasers+Surg+Med&amp;title=A+case+series+of+facial+depigmentation+associated+with+low+fluence+Q-switched+1,064+nm+Nd:YAG+laser+for+skin+rejuvenation+and+melasma&amp;author=NP+Chan&amp;author=SG+Ho&amp;author=SY+Shek&amp;author=CK+Yeung&amp;author=HH+Chan&amp;volume=42&amp;publication_year=2010&amp;pages=712-719&amp;pmid=20848553&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. <span><span class=\"ref-journal\">J Dermatol Sci. </span>2007;<span class=\"ref-vol\">46</span>:111–116.</span> [<a href=\"/pubmed/17363223\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Dermatol Sci. </span>,\n",
       " <span class=\"ref-vol\">46</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=The+vascular+characteristics+of+melasma&amp;author=EH+Kim&amp;author=YC+Kim&amp;author=ES+Lee&amp;author=HY+Kang&amp;volume=46&amp;publication_year=2007&amp;pages=111-116&amp;pmid=17363223&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. <span><span class=\"ref-journal\">Exp Dermatol. </span>2005;<span class=\"ref-vol\">14</span>:625–633.</span> [<a href=\"/pubmed/16026585\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Exp Dermatol. </span>,\n",
       " <span class=\"ref-vol\">14</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Exp+Dermatol&amp;title=Modulation+of+vascular+endothelial+growth+factor+receptors+in+melanocytes&amp;author=EJ+Kim&amp;author=HY+Park&amp;author=M+Yaar&amp;author=BA+Gilchrest&amp;volume=14&amp;publication_year=2005&amp;pages=625-633&amp;pmid=16026585&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Geddes ER, Stout AB, Friedman PM. Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma. <span><span class=\"ref-journal\">Dermatol Surg. </span>2016;<span class=\"ref-vol\">42</span>:556–559.</span> [<a href=\"/pubmed/26963145\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Dermatol Surg. </span>,\n",
       " <span class=\"ref-vol\">42</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Long-pulsed+dye+laser+of+595+nm+in+combination+with+pigment-specific+modalities+for+a+patient+exhibiting+increased+vascularity+within+lesions+of+melasma&amp;author=ER+Geddes&amp;author=AB+Stout&amp;author=PM+Friedman&amp;volume=42&amp;publication_year=2016&amp;pages=556-559&amp;pmid=26963145&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Lee HI, Lim YY, Kim BJ, Kim MN, Min HJ, Hwang JH, et al.  Clinicopathologic efficacy of copper bromide plus/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients. <span><span class=\"ref-journal\">Dermatol Surg. </span>2010;<span class=\"ref-vol\">36</span>:885–893.</span> [<a href=\"/pubmed/20482724\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Dermatol Surg. </span>,\n",
       " <span class=\"ref-vol\">36</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=Clinicopathologic+efficacy+of+copper+bromide+plus/yellow+laser+(578+nm+with+511+nm)+for+treatment+of+melasma+in+Asian+patients&amp;author=HI+Lee&amp;author=YY+Lim&amp;author=BJ+Kim&amp;author=MN+Kim&amp;author=HJ+Min&amp;volume=36&amp;publication_year=2010&amp;pages=885-893&amp;pmid=20482724&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Passeron T. Long-lasting effect of vascular targeted therapy of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>2013;<span class=\"ref-vol\">69</span>:e141–e142.</span> [<a href=\"/pubmed/23957991\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Am Acad Dermatol. </span>,\n",
       " <span class=\"ref-vol\">69</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Long-lasting+effect+of+vascular+targeted+therapy+of+melasma&amp;author=T+Passeron&amp;volume=69&amp;publication_year=2013&amp;pages=e141-e142&amp;pmid=23957991&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. <span><span class=\"ref-journal\">Arch Dermatol. </span>2011;<span class=\"ref-vol\">147</span>:1106–1108.</span> [<a href=\"/pubmed/21931054\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Arch Dermatol. </span>,\n",
       " <span class=\"ref-vol\">147</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Arch+Dermatol&amp;title=Melasma+treatment+with+pulsed-dye+laser+and+triple+combination+cream:+a+prospective,+randomized,+single-blind,+split-face+study&amp;author=T+Passeron&amp;author=E+Fontas&amp;author=HY+Kang&amp;author=P+Bahadoran&amp;author=JP+Lacour&amp;volume=147&amp;publication_year=2011&amp;pages=1106-1108&amp;pmid=21931054&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. <span><span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>2013;<span class=\"ref-vol\">27</span>:1035–1039.</span> [<a href=\"/pubmed/22329442\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Eur Acad Dermatol Venereol. </span>,\n",
       " <span class=\"ref-vol\">27</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&amp;title=Effect+of+tranexamic+acid+on+melasma:+a+clinical+trial+with+histological+evaluation&amp;author=JI+Na&amp;author=SY+Choi&amp;author=SH+Yang&amp;author=HR+Choi&amp;author=HY+Kang&amp;volume=27&amp;publication_year=2013&amp;pages=1035-1039&amp;pmid=22329442&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. <span><span class=\"ref-journal\">Dermatol Surg. </span>1999;<span class=\"ref-vol\">25</span>:18–22.</span> [<a href=\"/pubmed/9935087\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Dermatol Surg. </span>,\n",
       " <span class=\"ref-vol\">25</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Dermatol+Surg&amp;title=The+safety+and+efficacy+of+salicylic+acid+chemical+peels+in+darker+racial-ethnic+groups&amp;author=PE+Grimes&amp;volume=25&amp;publication_year=1999&amp;pages=18-22&amp;pmid=9935087&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. <span><span class=\"ref-journal\">J Am Acad Dermatol. </span>1986;<span class=\"ref-vol\">15</span>:894–899.</span> [<a href=\"/pubmed/3534025\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Am Acad Dermatol. </span>,\n",
       " <span class=\"ref-vol\">15</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Dermatol&amp;title=Usefulness+of+retinoic+acid+in+the+treatment+of+melasma&amp;author=MA+Pathak&amp;author=TB+Fitzpatrick&amp;author=EW+Kraus&amp;volume=15&amp;publication_year=1986&amp;pages=894-899&amp;pmid=3534025&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. <span><span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>2011;<span class=\"ref-vol\">60</span>:11–18.</span> [<a href=\"/pubmed/20937709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Electron Microsc (Tokyo) </span>,\n",
       " <span class=\"ref-vol\">60</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Electron+Microsc+(Tokyo)&amp;title=A+low+fluence+Q-switched+Nd:YAG+laser+modifies+the+3D+structure+of+melanocyte+and+ultrastructure+of+melanosome+by+subcellular-selective+photothermolysis&amp;author=JY+Mun&amp;author=SY+Jeong&amp;author=JH+Kim&amp;author=SS+Han&amp;author=IH+Kim&amp;volume=60&amp;publication_year=2011&amp;pages=11-18&amp;pmid=20937709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Kim JH, Kim H, Park HC, Kim IH. Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. <span><span class=\"ref-journal\">J Invest Dermatol. </span>2010;<span class=\"ref-vol\">130</span>:2333–2335.</span> [<a href=\"/pubmed/20463692\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Invest Dermatol. </span>,\n",
       " <span class=\"ref-vol\">130</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Invest+Dermatol&amp;title=Subcellular+selective+photothermolysis+of+melanosomes+in+adult+zebrafish+skin+following+1064-nm+Q-switched+Nd:YAG+laser+irradiation&amp;author=JH+Kim&amp;author=H+Kim&amp;author=HC+Park&amp;author=IH+Kim&amp;volume=130&amp;publication_year=2010&amp;pages=2333-2335&amp;pmid=20463692&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Na SY, Cho S, Lee JH. Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients. <span><span class=\"ref-journal\">Ann Dermatol. </span>2012;<span class=\"ref-vol\">24</span>:267–273.</span> <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span> [<a href=\"/pubmed/22879709\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">Ann Dermatol. </span>,\n",
       " <span class=\"ref-vol\">24</span>,\n",
       " <span class=\"nowrap\">[<a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>]</span>,\n",
       " <a class=\"int-reflink\" href=\"/pmc/articles/PMC3412234/\">PMC free article</a>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=Ann+Dermatol&amp;title=Intense+pulsed+light+and+low-fluence+Q-switched+Nd:YAG+laser+treatment+in+melasma+patients&amp;author=SY+Na&amp;author=S+Cho&amp;author=JH+Lee&amp;volume=24&amp;publication_year=2012&amp;pages=267-273&amp;pmid=22879709&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <span class=\"element-citation\">Park GH, Lee JH, Choi JR, Chang SE. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment. <span><span class=\"ref-journal\">J Dermatolog Treat. </span>2013;<span class=\"ref-vol\">24</span>:297–299.</span> [<a href=\"/pubmed/22136311\" ref=\"reftype=pubmed&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord\" target=\"pmc_ext\">PubMed</a>] <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span></span>,\n",
       " <span class=\"ref-journal\">J Dermatolog Treat. </span>,\n",
       " <span class=\"ref-vol\">24</span>,\n",
       " <span class=\"nowrap\">[<a href=\"https://scholar.google.com/scholar_lookup?journal=J+Dermatolog+Treat&amp;title=The+degree+of+erythema+in+melasma+lesion+is+associated+with+the+severity+of+disease+and+the+response+to+the+low-fluence+Q-switched+1064-nm+Nd:YAG+laser+treatment&amp;author=GH+Park&amp;author=JH+Lee&amp;author=JR+Choi&amp;author=SE+Chang&amp;volume=24&amp;publication_year=2013&amp;pages=297-299&amp;pmid=22136311&amp;\" ref=\"reftype=other&amp;article-id=5762458&amp;issue-id=304545&amp;journal-id=1223&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar\" target=\"pmc_ext\">Google Scholar</a>]</span>,\n",
       " <div class=\"courtesy-note whole_rhythm small\"><hr/>Articles from <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span> are provided here courtesy of <strong>Korean Dermatological Association and Korean Society for Investigative Dermatology</strong></div>,\n",
       " <span class=\"acknowledgment-journal-title\">Annals of Dermatology</span>,\n",
       " <div class=\"col6\">\n",
       " </div>,\n",
       " <div class=\"format-menu\"><h2>Formats:</h2><ul><li class=\"selected\">Article</li> | <li><a href=\"/pmc/articles/PMC5762458/?report=reader\">PubReader</a></li> | <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li> | <li><a href=\"/pmc/articles/PMC5762458/pdf/ad-30-1.pdf\">PDF (11M)</a></li> | <li><a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a></li></ul></div>,\n",
       " <li class=\"selected\">Article</li>,\n",
       " <li class=\"epub-link\"><a href=\"/pmc/articles/PMC5762458/epub/\">ePub (beta)</a></li>,\n",
       " <a class=\"citationexporter ctxp\" data-citationid=\"PMC5762458\" href=\"#\">Citation</a>,\n",
       " <div class=\"share-buttons\" xmlns:np=\"http://ncbi.gov/portal/XSLT/namespace\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><h2>Share</h2><ul><li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li><li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li><li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li></ul></div>,\n",
       " <li class=\"facebook\"><a href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Facebook\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626\"/>\n",
       "                              Facebook\n",
       "                         </a></li>,\n",
       " <li class=\"twitter\"><a href=\"https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;text=Treatment%20of%20Melasma%20with%20Pulsed-Dye%20Laser%20and%201%2C064-nm%20Q-Switched%20Nd%3AYAG%20Laser%3A%20A%20Split-Face%20Study\"><img alt=\"Share on Twitter\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627\"/>\n",
       "                              Twitter\n",
       "                         </a></li>,\n",
       " <li class=\"gplus\"><a href=\"https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F\"><img alt=\"Share on Google Plus\" src=\"//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628\"/>\n",
       "                              Google+\n",
       "                         </a></li>,\n",
       " <div class=\"col7\">\n",
       " </div>,\n",
       " <div class=\"col8\">\n",
       " </div>,\n",
       " <div class=\"col9\">\n",
       " </div>,\n",
       " <div class=\"bottom\">\n",
       " <div id=\"NCBIFooter_dynamic\">\n",
       " <a class=\"help_desk\" href=\"\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " <a class=\"help_desk\" href=\"https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-08T00:03:47-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89173EDC4F41510000000001AD011A&amp;ncbi_session=CE89173EDC4F7321_0429SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5762458%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049\" id=\"help-desk-link\" target=\"_blank\">Support Center</a>\n",
       " </div>\n",
       " <div class=\"footer\" id=\"footer\">\n",
       " <div class=\"subfooter\"> </div><script src=\"/portal/portal3rc.fcgi/static/js/preloaderWidget.js\" type=\"text/javascript\"> </script>\n",
       " <div class=\"offscreen_noflow\" id=\"external-disclaimer\">\n",
       "         External link. Please review our <a href=\"https://www.nlm.nih.gov/privacy.html\">privacy policy</a>.\n",
       "     </div>\n",
       " <div class=\"contact_info\" id=\"ncbifooter\">\n",
       " <div id=\"footer-contents-right\">\n",
       " <div id=\"nlm_thumb_logo\">\n",
       " <a href=\"https://www.nlm.nih.gov\" title=\"NLM\">NLM</a>\n",
       " </div>\n",
       " <div id=\"nih_thumb_logo\">\n",
       " <a href=\"https://www.nih.gov\" title=\"NIH\">NIH</a>\n",
       " </div>\n",
       " <div id=\"hhs_thumb_logo\">\n",
       " <a href=\"https://www.hhs.gov\" title=\"DHHS\">DHHS</a>\n",
       " </div>\n",
       " <div id=\"usagov_thumb_logo\">\n",
       " <a href=\"https://www.usa.gov\" title=\"USA.gov\">USA.gov</a>\n",
       " </div>\n",
       " </div>\n",
       " <div id=\"footer-contents-left\">\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>\n",
       " <a href=\"/home/about/policies.shtml\">Policies and Guidelines</a> | <a href=\"/home/about/contact.shtml\">Contact</a>\n",
       " </div>\n",
       " </div>\n",
       " <script src=\"/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1\" type=\"text/javascript\"> </script>\n",
       " <script src=\"/portal/portal3rc.fcgi/static/js/hfjs2.js\" type=\"text/javascript\"> </script>\n",
       " </div>\n",
       " </div>,\n",
       " <div class=\"subfooter\"> </div>,\n",
       " <p class=\"address vcard\">\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span> <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>\n",
       " </p>,\n",
       " <span class=\"url\">\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       "                 </span>,\n",
       " <a class=\"fn url newdomain\" href=\"https://www.ncbi.nlm.nih.gov\">National Center for\n",
       "                         Biotechnology Information</a>,\n",
       " <span class=\"org url newdomain\"><a href=\"https://www.nlm.nih.gov/\">U.S. National Library of Medicine</a></span>,\n",
       " <span class=\"adr\">\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>, <span class=\"locality\">Bethesda</span>\n",
       " <span class=\"region\">MD</span>, <span class=\"postal-code\">20894</span>\n",
       " <span class=\"country-name\">USA</span>\n",
       " </span>,\n",
       " <span class=\"street-address\">8600 Rockville Pike</span>,\n",
       " <span class=\"locality\">Bethesda</span>,\n",
       " <span class=\"region\">MD</span>,\n",
       " <span class=\"postal-code\">20894</span>,\n",
       " <span class=\"country-name\">USA</span>,\n",
       " <span class=\"PAFAppResources\"></span>]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def has_class_but_no_id(tag):\n",
    "    return tag.has_attr('class') and not tag.has_attr('id')\n",
    "soup.find_all(has_class_but_no_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
